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1. Introduction  
1.1 Historical development  
L-asparaginases (EC 3.5.1.1) catalyze the hydrolysis of L-asparagine to L-aspartic 
acid and ammonia. Both the substrates and the product of this enzymatic reaction play 
important roles in a number of metabolic processes in all organisms, from bacteria to 
mammals. The interest in asparaginases was greatly enhanced by the fact that some of these 
enzymes exhibit anti-tumor activity. In 1922, Clementi tested mammalian sera for 
asparaginase activity and found significant activity only in guinea pig serum (Clementi, 
1922). In 1953, John Kidd in New York observed that guinea pig serum inhibits tumor 
growth in rats and mice and suggested that the active material was a protein (Kidd, 1953). 
Ten years later Broome showed that it was not the complement in the serum which provoked 
the tumor regression as first assumed, but rather the enzyme L-asparaginase (Broome, 1963).  
He confirmed the results of Clementi’s work from the early 1920s and showed that a 
correlation existed between his results and those of Kidd. Soon after Broome’s finding, an 
asparaginase was isolated from Escherichia coli B that was much more efficient in to 
inducing remissions in children with acute lymphoblastic leukemia (Mashburn & Wriston, 
1964; Hill et al., 1967; Oettgen et al., 1967). The E. coli enzyme and several others were 
purified and studied by a number of researchers leading to the explosive growth of this area 
of research.  
 
1.2 Bacterial amidohydrolases 
On the basis of their substrate specificity, bacterial L-amidohydrolases can be 
assigned to two major classes. Enzymes of the first class are true asparaginases (EC 3.5.1.1) 
which primarily utilize L-asparagine as a substrate. The enzymes belonging to the second 
class, also referred to as glutaminase-asparaginase (EC 3.1.5.38), catalyze the hydrolysis of 
both L-asparagine and L-glutamine with comparable efficiency. 
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Figure 1.1 Reactions catalyzed by 
bacterial amidohydrolases.  
The substrates asparagine (n=1) or 
glutamine (n=2) are hydrolyzed to  
the corresponsing dicarboxylates, 
aspartate and glutamate. 
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Another distinction refers to the subcellular localization of these enzymes. Type I 
amidohydrolases are low-affinity cytosolic enzymes, while type II asparaginases are located 
in the periplasm of Gram-negative bacteria and have a much higher affinity for their 
substrates. Both amidohydrolase types are found in many bacterial species, but only type II 
enzymes from Escherichia coli (E. coli asparaginase II) and a related enzyme from Erwinia 
chrysanthemi are being used for leukemia treatment. In 1969, EcA2 was obtained in a 
crystalline form for the first time (Ho et al., 1969) and its crystal structure was solved in 
1992 (Swain et al., 1993). Today the structures of five type II amidohydrolases are known 
(enzymes from E. coli, Erwinia, Acinetobacter, Wolinella succinogenes and Pseudomonas 
spec.) 
 
1.3 Mechanism of action of asparaginase as a drug 
It is now well established that the antineoplastic activity of asparaginases is mainly 
due to the depletion of asparagine in the blood serum. Certain lymphosarcomas and the 
leukocytes transformed in acute lymphatic leukemia (ALL), unlike normal cells, cannot 
compensate for the lack of asparagine, because they show a diminished expression of 
asparagine synthetase (Haskell and Canellos, 1969). Therefore, these cells depend on an 
extracellular supply of L-asparagine which they obtain from the circulating pools (Rogers, 
1989). Intravenous treatment with asparaginase leads to depletion of the supply of asparagine 
and can thus be cytotoxic for the neoplastic cells (Bauer, 1969).  
 
 
Fig 1.2  Mechanism of the anti-tumor activity of L-asparaginase. 
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The inclusion of asparaginase in the combination chemotherapy of ALL leads to 
markedly longer period of sustained remission and fewer relapses (Clavell et al., 1986; 
Nesbit et al., 1981). L-asparaginase in combination with methotrexate and other drugs is 
highly effective in the therapy of both primary and acute lymphoblastic leukemia of children 
and adults (Capizzi, 1981, 1983). At a later stage, the continued application of asparaginase 
helps to prevent further outbreaks (Mueller & Boos, 1998).  
 Unfortunately, the therapy with asparaginases may have serious side effects on 
pancreas, liver, blood coagulation and the CNS (Haskell et al., 1969; Whitecar et al., 1970, 
Gralnick and Henry, 1969). In addition, the L-asparaginase enzyme is not very stable in 
blood plasma, which limits its use in treatment of leukaemia.    
 Two factors important for the antineoplastic activity of asparaginases are the Km 
values for asparagine and the rate of clearance from circulation. The more rapidly an enzyme 
is removed from circulation, the lower its antineoplastic activity. The half-life for clearance 
of guinea pig L-asparaginase from the serum of patients is about 8 h (Boyse et al., 1967) and 
that of E. coli L-asparaginase has been shown to vary between 8 to 24 h (Tomao et al., 1969). 
 
1.4 Escherichia coli asparaginases  
 Escherichia coli contain two L-asparaginase isozymes that can be separated by 
standard protein fractionation techniques (Schwartz et al., 1966; Campbell et al., 1967). 
These enzymes have been designated EC1 and EC2 in E. coli B (Campbell et al., 1967), or 
EcA1 and EcA2 in E. coli K-12 (Cedar and Schwartz 1967). The amino acid sequences of 
EcA1 and EcA2 are rather dissimilar except for a few regions of significant homology (Maita 
and Matsuda et al., 1986, Jerlstörm et al., 1989, cf. Figure 1.3). In this work we use the 
abbreviations EcA1 and EcA2, respectively for E. coli asparaginase isozymes 1 or 2.  
 
1.4.1  Properties 
Cedar and Schwartz (1967) first showed that EcA2, but not EcA1, is secreted into the 
surrounding medium, both during the formation of spheroplast by treatment with lysozyme 
and EDTA, and after osmotic shock. It was concluded that EcA2 is located in the periplasmic 
space, between the bacterial plasma membrane and the outer membrane, while EcA1 is 
cytoplasmic. 
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 EcA2 is regulated by the oxygen level in the medium, with the high level of induction 
under anaerobic conditions (Cedar and Schwartz, 1967, 1968). In contrast, no definite form 
of regulation has been reported for EcA1, which is considered a constitutive enzyme 
(Jerlström, 1989). 
 Apart from their differing cellular location and regulation, the E .coli enzymes differ 
with respect to their catalytic properties.  EcA1 and EcA2 have Km values for asparagine of 
3.5 mM and 11.5 µM, respectively (Ho and Milikin, 1970). The active form of EcA1 was 
reported to be a dimer with a subunit mass of 35.4 kDa (Jerlstroem, 1989), although recent 
results suggest a tetrameric structure. The active form of EcA2 is a homotetramer with a 
mass of 4 x 34.6 kDa (Maita and Matsuda, 1980). 
The amino acid sequence of EcA2 has been determined by protein sequencing in the 
seventies (Maita et al., 1974). In 1990 the nucleotides sequence of the ansB gene was 
reported by Beacham and coworkers (Figure 1.3). The EcA2 precursor has a 22-residue N-
terminal signal peptide which is cleaved between residues 22 and 23 to yield the mature 
protein with N-terminal leucine residues. The mature enzyme consists of 326 amino acids 
with a calculated molecular weight of 34594. The primary structure as deducted from the 
nucleotide sequence is also shown in figure 1.3. The other type II  asparaginases are highly 
homologous to EcA2. A sequence alignment of several high-affinity asparaginases is shown 
in figure 1.4. 
The production of E. coli L-asparaginase is regulated by two pleitropic regulatory 
proteins i.e. the FNR protein (Jelström et al., 1987) which activates a number of genes during 
anaerobiosis (Unden and Guest, 1984; Jayaram et al., 1987; Spiro and Guest, 1987) and the 
cyclic AMP receptor protein CRP (Chesney, 1983; Russell and Yamazaki, 1978) which 
controls the initiation of transcription of genes in various catabolic pathways (De 
Crombrugghe et al., 1984; Ebright and Beckwith, 1985; Harms et al., 1991). 
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                    Met GLu Phe Phe Lys Lys Thr Ala Leu Ala Ala Leu Val Met Gly 
  GTAACTGGAGGAATGAA ATG GAG TTT TTC AAA AAG ACG GCA CTT GCC GCA CTG GTT ATG GGT 
                                
Phe Ser Gly Ala Ala Leu Ala Leu Pro Asn Ile Thr Ile Leu Ala Thr Gly Gly Thr Ile 
TTT AGT GGT GCA GCA TTC GCA TTA CCC AAT ATC ACC ATT TTA GCA ACC GGC GGG ACC ATT 
                         20                                      30 
Ala Gly Gly Gly Asp Ser Ala Thr Lys Ser Asn Tyr Thr Val Gly Lys Val Gly Val Glu 
GCC GGT GGT GGT GAC TCC GCA ACC AAA TCT AAC TAC ACA GTG GGT AAA GTT GGC GTA GAA 
                         40                                      50 
Asn Leu Val Asn Ala Val Pro Gln Leu Lys Asp Ile A1a Asn Val Lys Gly Glu Gln Val 
AAT CTG GTT AAT GCG GTG CCG CAA CTA AAA GAC ATT GCG AAC GTT AAA GGC GAG CAG GTA 
                         60                                      70 
Val Asn Ile Gly Ser Gln Asp Met Asn Asp Asn Val Trp Leu Thr Leu Ala Lys Lys Ile 
GTG AAT ATC GGC TCC CAG GAC ATG AAC GAT AAT GTC TGG CTG ACA CTG GCG AAA AAA ATT 
                         80                                      90 
Asn Thr Asp Cys Asp Lys Thr Asp Gly Phe Val Ile Thr His Gly Thr Asp Thr Met Glu 
AAC ACC GAC TGC GAT AAG ACC GAC GGC TTC GTC ATT ACC CAC GGT ACC GAC ACC ATG GAA 
                        100                                     110 
Glu Thr Ala Tyr Phe Leu Asp Leu Thr Val Lys Cys Asp Lys Pro Val Val Met Val Gly 
GAA ACT GCT TAC TTC CTC GAC CTG ACC GTG AAA TGC GAC AAA CCG GTG GTG ATG GTC GGC 
                        120                                     130 
Ala Met Arg Pro Ser Thr Ser Met Ser Ala Asp Gly Pro Phe Asn Leu Tyr Asn Ala Val 
GCA ATG CGT CCG TCC ACG TCT ATG AGC GCA GAC GGT CCA TTC AAC CTG TAT AAC GCG GTA 
                        140                                     150 
Val Thr Ala Ala Asp Lys Ala Ser Ala Asn Arg Gly Val Leu Val Val Met Asn Asp Thr 
GTG ACC GCA GCT GAT AAA GCC TCC GCC AAC CGT GGC GTG CTG GTA GTG ATG AAT GAC ACC 
                        160                                     170 
Val Leu Asp Gly Arg Asp Val Thr Lys Thr Asn Thr Thr Asp Val Ala Thr Phe Lys Ser 
GTG CTT GAT GGC CGT GAC GTC ACC AAA ACC AAC ACC ACC GAC GTA GCG ACC TTC AAG TCT 
                        180                                     190 
Val Asn Tyr Gly Pro Leu Gly Tyr Ile His Asn Gly Lys Ile Asp Tyr Gln Arg Thr Pro 
GTT AAC TAC GGT CCT CTG GGT TAC ATT CAC AAC GGT AAG ATT GAC TAC CAG CGT ACC CCG 
                        200                                     210 
Ala Arg Lys His Thr Ser Asp Thr Pro Phe Asp Val Ser Lys Leu Asn G1u Leu Pro Lys 
GCA CGT AAG CAT ACC AGC GAC ACG CCA TTC GAT GTC TCT AAG CTG AAT GAA CTG CCG AAA 
                        220                                     230 
Val Gly Ile Val Tyr Asn Tyr Ala Asn Ala Ser Asp Leu Pro Ala Lys Ala Leu Val Asp 
GTC GGC ATT GTT TAT AAC TAC GCT AAC GCA TCC GAT CTT CCG GCT AAA GCA CTG GTA GAT 
                        240                                     250 
Ala Gly Tyr Asp Gly Ile Val Ser Ala Gly Val Gly Asn Gly Asn Leu Tyr Lys Ser Val 
GCG GGC TAT GAT GGC ATC GTT AGC GCT GGT GTG GGT AAC GGC AAC CTG TAT AAA TCT GTG 
                        260                                     270 
Phe Asp Thr Leu Ala Thr Ala A1a Lys Thr Gly Thr A1a Val Val Arg Ser Ser Arg Val 
TTC GAC ACG CTG GCG ACC GCC GCG AAA ACC GGT ACT GCA GTC GTG CGT TCT TCC CGC GTA 
                        280                                     290 
Pro Thr Gly Ala Thr Thr Gln Asp Ala Glu Val Asp Asp Ala Lys Tyr Gly Phe Val Ala 
CCG ACG GGC GCT ACC ACT CAG GAT GCC GAA GTG GAT GAT GCG AAA TAC GGC TTC GTC GCC 
                        300                                     310 
Ser Gly Thr Leu Asn Pro Gln Lys Ala Arg Val Leu Leu Gln Leu Ala Leu Thr Gln Thr 
TCT GGC ACG CTG AAC CCG CAA AAA GCG CGC GTT CTG CTG CAA CTG GCT CTG ACG CAA ACC 
                        320 
Lys Asp Pro Gln Gln Ile Gln Gln Ile Phe Asn Gln Tyr  * 
AAA GAT CCG CAG CAG ATC CAG CAG ATC TTC AAT CAG TAC TAA TCGCCTCGCCCCGGTATCGTGC 
 
Figure 1.3 Nucleotide and predicted sequence of the ansB gene (Jennings and Beacham, 1990).  
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   1          *     20     *            40 
E.coli II --LPNITILATGGTIAGGGDSATKSN-YTVGKVGVENLVNAVPQLKDIANVKGEQVVNIG 
A.glut.II --KNNVVIVATGGTIAGAGASSTNSATYSAAKVPVDALIKAVPQVNDLANITGIQALQVA 
Er.chry.II DKLPNIVILATGGTIAGSAATGTQTTGYKAGALGVDTLINAVPEVKKLANVKGEQFSNMA 
S.cere II SSLPSIKIFGTGGTIASKGSTSATTAGYSVGLT-VNDLIEAVPSLAEKANLDYLQVSNVG 
B. sub.I --MKKLLMLTTGGTIAS----VEGENGLAPGVK-ADELLSYVSKLDNDYTMETQSLMNID 
E.coli I MQKKSIYVAYTGGTIGMQ-RSEQGYIPVSGHLQRQLALMPEFHRPEMPDFTIHEYTPLMD 
  *60                   80       **       100 
E.coli II SQDMNDNVWLTLAKKINTDCDK--TDGFVITHGTDTMEETAYFLDLTVK-CDKPVVMVGA 
A.glut.II SESITDKELLSLARQVNDLVKKPSVNGVVITHGTDTMEETAFFLNLVVH-TDKPIVLVGS 
Er.chry.II SENMTGDVVLKLSQRVNELLARDDVDGVVITHGTDTVEESAYFLHLTVK-SDKPVVFVAA 
S.cere II SNSLNYTHLIPLYHGISEALASDDYAGAVVTHGTDTMEETAFFLDLTIN-SEKPVCIAGA 
B. sub.I STNMQPEYWVEIAEAVKENYDA--YDGFVITHGTDTMAYTSAALSYMLQHAKKPIVITGS 
E.coli I SSDMTPEDWQHIAEDIKAHYDD--YDGFVILHGTDTMAYTASALSFMLENLGKPVIVTGS 
    120                140                160 * 
E.coli II MRPSTSMSADGPFNLYNAVVTAADKASANRGVLVVMNDTVLDGRDVTKTNTTDVATFKSV 
A.glut.II MRPSTALSADGPLNLYSAVALASSNEAKNKGVMVLMNDSIFAARDVTKGINIHTHAFVS- 
Er.chry.II MRPATAISADGPMNLLEAVRVAGDKQSRGRGVMVVLNDRIGSARYITKTNASTLDTFKAN 
S.cere II MRPATATSADGPMNLYQAVSIAASEKSLGRGTMITLNDRIASGFWTTKMNANSLDTFRAD 
B. sub.I QIPITFQKTDAKKNITDAIRFACEGVG---GVYVVFDGRVIQGTRAIKLRTKSYDAFESI 
E.coliI QIPLAELRSDGQINLLNALYVAANYPIN--EVTLFFNNRLYRGNRTTKAHADGFDAFASP 
    180                200                   220 
E.coli II NYGPLGYIHNGKIDYQRTPARKHTSDTPFDVSKLN---ELPKVGIVYNYANA-SDLPAKA 
A.glut.II QWGALGTLVEGKPYWFRSSVKKHTNNSEFNIEKIQG-DALPGVQIVYGSDNM-MPDAYQA 
Er.chry.II EEGYLGVIIGNRIYYQNRIDKLHTTRSVFDVRGLT---SLPKVDILYGYQDD-PEYLYDA 
S.cereII EQGYLGYFSNDDVEFYYPPVKPN-GWQFFDISNLTDPSEIPEVIILYSYQGLNPELIVKA 
B. sub.I NYPYIAFINEDGIEYNKQVTEPENDTFTVDTSLCT------DVCLLKLHPGL-KPEMFDA 
E.coli I NLPPLLEAG-IHIRRLNTPPAPH-GEGELIVHPITP----QPIGVVTIYPGI-SADVVRN 
        240                   260                   280  * 
E.coli II LVDAGYDGIVSAGVGNGNLY---KSVFDTLATAAKTGTAVVRSSR-VPTG--ATTQDAEV 
A.glut.II FAKAGVKAIIHAGTGNGSMAN--YLVPEVRKLHDEQGLQIVRSSR-VAQG--FVLRNAEQ 
Er.chry.II AIQHGVKGIVYAGMGAGSVSV--RGIAGMRKAMEK-GVVVIRSTR-TGNG--IVPPDEEL 
S.cere II VKDLGAKGIVLAGSGAGSWTA--TGSIVNEQLYEEYGIPIVHSRR-TADG--TVPPDDAP 
Bsub.I LKSM-YKGIVIESYGSGGVPFEGRDILSKVNELIESGIVVVITTQCLEEGEDMSIYEVGR 
E.coli I FLRQPVKALILRSYGVGNAPQ-NKAFLQELQEASDRGIVVVNLTQCMSGKVNMGGYATGN 
              300                320 
E.coli II DDAKYGFVASGTLNPQKARVLLQLALTQTKDPQQIQQIFN-QY-------- 
A.glut.II PDDKYGWIAAHDLNPQKARLLMALALTKTNDAKEIQNMFW-NY-------- 
Er.chry.II PG-----LVSDSLNPAHARILLMLALTRTSDPKVIQEYFH-TY-------- 
S.cere II EYA----IGSGYLNPQKSRILLQLCLYSGYGMDQIRSVFSGVYGG------ 
B. sub.I RVNQDLIIRSRNMNTEAIVPKLMWALGQSSDLPVVKRIMETPIADDVVL-- 
E.coli I ALAHAGVIGGADMTVEATLTKLHYLLSQELDTETIRKAMSQNLRGELTPDD 
 
Figure 1.4 Sequence alignment of different asparaginases. Highly conserved sequences are shown in shaded 
print. The amino acids taking part in the formation of the tetramer in E. coli asparaginase II are printed in bold. 
Amino acids present at the B/C or A/D interfaces are underlined. The amino acids present at the B/A or D/C 
interfaces are underlined  by a dotted line. Amino acids present on all interfaces are double underlined. Stars (*) 
indicate catalytically important residues. 
 
The sequences shown are: E. coli II – Asparaginase II from Escherichia coli [Jennings and Beacham, 1990],  
A. glutam II - Glutaminase-Asparaginase (Typ II) from Acinetobacter glutaminasificans [Harrison et al., 1987], 
Er. chry. II Asparaginase (Typ II) from Erwinia chrysanthemi [Minton et al., 1986], S. cere II Asparaginase 
(Typ II) from Saccharomyces cerevisea [Kim et al., 1988], B. sub. I Asparaginase (Typ I) from Bacillus subtilis 
[Sun und Setlow, 1991], and E. coli I Asparaginase (Typ I ) from Escherichia coli [Jerlström et al., 1989]  
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1.4.2   Structure of E. coli asparaginase II  
 
 The crystal structure of the E. coli asparaginase II (EcA2) has been determined to 2.3 
Å resolution by A. Woldawer and his colleagues (Swain et al., 1993). During the last years, 
the structures of several other asparaginases have been solved [Swain et al., 1993; 
Lubkowski et al., 1996; Rao et al., 1996]  
1.4.2.1 Tertiary and quaternary structure 
 The asparaginase subunit (Figure 1.5) consists of two α/β domains that are connected 
by a linking sequence involving residues 191-222 (blue). The N-terminal domain (top) 
contains an eight-stranded mixed β-sheet and four α–helices. A disulfide bridge is located 
between the residues Cys77 and Cys105 of N-terminal domain (Greenquist and Wriston, 
1972). The smaller C-terminal domain (bottom, residues 213-326) consists of a four stranded 
parellel β–sheet and four β-helices. 
 
 
The native tetrameric form of EcA2 is composed of four identical subunits, A, B, C, 
and D, with 222 symmetry (Figure 1.6). There are six pairwise interactions among the 
Figure 1.5  Schematic representation 
of the EcA2 monomer. Secondary 
structure elements in both the N-terminal 
(top) and C-terminal domain are shown 
in different colours. (Palm et al., 1997) 
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subunits. The interactions between subunit A and C and between B and D, respectively,  
form two ‘intimate’ pair of subunits. Therefore, the tetramer is best described as a dimer of 
identical dimers.  
 
A C
B D
 
 
 
 
Dimer-dimer
Interface
(Y176/Y181)
Bound 
Asp
W66
a b
 
 
 
 
The asparaginase tetramer has four active sites. Their location has been identified by 
the presence of the bound aspartate, which is clearly visible in the electron density map. The 
active sites are located between subunits in the intimate dimers, so that each dimer has two 
active sites. Each of the four active sites of L-asparaginase is located between the N- and C- 
terminal domains of two adjacent monomers.  
 
 
Figure 1.6 Quaternary Structure 
of EcA2. Subunits A (yellow) and 
C (light yellow), or B (light blue) 
and D (blue), respectively, form 
structurally equivalent dimers.   
(a) Each monomer contains one 
active site indicated by bound 
aspartate (red). W66 buried in the 
interior of subunit (pink). Residues 
Y176 and Y181 at the A/D and 
B/C interfaces are represented by 
the green surface (b) Model rotated 
by 90o.  
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1.4.2.2 Dimer-dimer interfaces 
Each EcA2 subunit has two areas of contact with either subunit of other "intimate 
dimer". In Figure 1.7 this is illustrated for subunit A which forms interfaces with subunits B 
and D, respectively (B-A and D-A). Corresponding interfaces exist for the other subunits as 
well. Some prominent residues at each interface are indicated in Figure 1.7. These are S122 
and D124 for the B-A contact and the tyrosines Y176 and Y181 at the D-A contact site.   
 
Figure 1.7  Important residues at the AB and AD interfaces of wild-type EcA2. 
 
Previous experiments from our group have shown that a S122A mutant exhibited 
little change in its kinetic properties and showed normal stability in urea solutions (Derst et 
al., 1992). The stability of a D124A mutant, on the other hand, was strongly impaired 
stability even in the absence of denaturants (Schubert et al., 1996). 
  The local structure at the A/D interface is shown in more detail in Figure 1.8. 
Hydrogen bonds (green) connect the phenolic OH-groups of Y176 and Y181 with the 
backbone carbonyl oxygens of residues D188 and N175 in the opposing subunit. Salt bridges 
                                                                                                                 Chapter 1. Introduction  
 
 10 
(red) connect the carboxylate groups of D188 and D156 with the guanido groups of R195 
and R191 in the opposing subunit. 
 
D188(COO -)···R195(Gua+)
D188(C=O) ···Y176(OH)
Y181(OH) ··· N175(C=O)
R191(Gua+) ···D156(COO -)
D188(COO -) ···R195(Gua+)
D188(C=O) ···Y176(OH)
Y181(OH) ··· N175(C=O)
R191(Gua+) ···D156(COO -)
 
Figure 1.8 Hydrophobic and electrostatic interactions at the dimer-dimer (A/D) interface of 
EcA2 (PDB entry 3eca). Hydrogen bonds are shown in green dashed lines and salt bridges are 
shown as red dashed lines. The figure was created with WebLab Viewer. 
 
 One of the residues at the A/D interface, Y181, has been included in a mutagenesis 
study before. A Y181S mutant showed a complex denaturation profile in guanidine 
hydrochloride with the significant appearance of a folding intermediate (Wehner 1992; Derst 
1994). 
  
1.5 Active center and mechanism of catalysis 
 An extensive-site directed mutagenesis study of Escherichia coli asparaginase II 
(Wehner et al., 1994; Aung, H.P, 1997) together with the information from X-ray 
crystallography (Palm et al., 1996) revealed a number of amino acid residues that are 
important for catalysis and substrate binding. Among them Tyr 25, Thr 12, Thr 89 and Lys 
162 play a catalytic role, while Asp 90, Ser 58, Asn 248 and Glu 283 assist substrate binding 
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(Wehner et al., 1994). The structural data show that all these essential residues are located in 
the active sites (Palm et al., 1996). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9 Stereo view of the EcA2 active site (from Derst et al., 2000). Open circles indicate 
conserved water molecules. 
 
Ser 58, Ala 114, Asp 90 and Glu 283 mediate substrate binding by direct hydrogen 
bonding interactions with the substrate. The residues important for catalysis include Lys 162, 
Thr 89, Tyr 25, and Thr 12. They directly interact with the substrate through Asp 90 and Glu 
283 by hydrogen bonding (Derst et al., 2000). One half of the active sites is covered by a 
flexible loop containing Thr 12 and Tyr 25 (Aung et al., 2000).  
The hydoxyl group of Thr 12 and Thr 89 are closest to the side chain carboxylate of 
bound aspartate and thus the most likely candidate for the catalytic nucleophile. In fact, the 
activity of mutant Thr89Val is decreased by factor of 25,000 (Palm et al., 1996) while the 
activity of mutant enzyme Thr12Ala is only 0.02% of that of wild type (Harms et al., 1991). 
This means that both hydroxyl groups in position 89 and in position 12 are absolutely 
required for catalysis. In agreement with this assumption, the activity of mutant enzyme 
Thr89Ser reaches 20% of that of the wild type and mutant Thr12Ser is also quite active 
(Palm et al., 1996). 
In the active center of E. coli asparaginase II, there are two groups of three amino 
acids each (‘triads’). One of the putative triads contains Thr 89, Lys 162, and Asp 90, while 
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the other one is formed by Thr 12, Tyr 25 and Glu 283 (Derst et al. 2000). The residues in 
the triad are also connected through hydrogen bonds. These structures resemble the catalytic 
triad of the serine proteinase which is made up by an aspartate, a histidine, and a serine 
residues.  
Normally ionization of the serine side chain is insignificant because of its high pKa = 
14. In serine proteinases and other enzymes with similar mechanism the partial negative 
charge on the oxygen atom is due to activation by a nearby histidine, which accepts a proton 
and thus increases the nucleophilicity of the serine side chain (Blow et al., 1969; Bachovchin 
and Roberts, 1978). However, it is not clear whether, in the bacterial asparaginases, Lys 162 
can play the same role as histidine in the serine proteinase, since its pKa should be too high to 
allow a function as a base down to pH 5. 
A series of further amino acid residues line the active site without being essential for 
catalysis. These residues were replaced with other amino acids of different and polarity by 
using systematic site-directed mutagenesis (Derst et al. 2000). Theses residues include Gly 
11 and Gly 88, both of which are immediately adjacent to the catalytic threonine. Gly 57 and 
Gln 59 are located on either side of Ser 58, a residue important for substrate binding: Val 27, 
which lines the active lines at the left and Asn 248 of another subunit comes in the active site 
from the right. Asn 248 is engaged in hydrogen bonds with residues Asp90 and Glu283. 
Mutants of Gly11, Gly88, Gly57 and Gln 59 showed reduced glutaminase activity. From the 
kinetics and stability data, it became clear that in EcA2, residues Gln 59 and Asn 248 both 
modulate substrate specificity in a selective manner. 
1.6 Expressions system (Harms et al., 1991) 
 Harms et al. have described the construction of expression vector pTWE1 for E. coli 
asparaginase II, a derivative of pT7-7 (Tabor and Richardson, 1985). The expression plasmid 
pTWE1 is shown in figure 1.5. From this plasmid the ansB gene will be transcribed from the 
bacteriophage T7 promoter Φ10 when transformed in the E .coli strain BL21 (CU1783). 
The gene for the β-lactamase causes the Ampicillin-resistance.  
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Figure 1.5  Expression plasmid pTWE1.  
MCS: remnants of multiple cloning site 
pT7: Promotor for T7-RNA-Polymerase 
ori: ColEI origin of replication 
 bla: Gene for -Lactamase 
(Harms et al., 1991) 
 
EcA2 mutants are denoted by AS1nnnAS2 where n specifies the sequence position, 
while AS1 correspond to wild-type amino acid and AS2 the mutant residue. e.g. Y176S 
means that the original tyrosine residue at position 176 is replaced with serine. 
The following nomenclature is used for expression plasmids: 
1) pT7-7                   Plasmid without the asparaginase (ansB) gene 
2) pTWE 1               Plasmid with wild-type ansB 
3) pTWE*                Plasmid with mutant ansB* 
4) pTWE/Y176S                Plasmid with ansB/Y176S 
5) CU1783/ pTWE/Tyr176Ser           Bacterial host cell containing pTWE/Tyr176Ser 
 
1.7 Aims and outlines of the studies 
 There is a direct relationship between the stability and the therapeutic activity of any 
protein. A key factor for the stability of oligomeric protein is the interactions between its 
subunits. Very limited information is available on the interactions that stabilize the native 
oligomeric state of large proteins.  
 EcA2 is as an excellent model to study the interactions that stabilize the native 
oligomeric state of large proteins:  
• High-resolution crystal structures are available (Swain et al., 1993).  
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• The protein unfolds and refolds reversibly in chemical denaturation, and it is readily 
amenable to site-directed mutagenesis. 
• There is only one tryptophan residue (W66) per subunit, localized in an unpolar 
environment in the native enzyme (Homer, 1972) which simplifies spectroscopic 
analysis of folding/ unfolding and dissociation/association phenomenon. 
            Using equilibrium and kinetic methods we analyzed such processes with wild-type 
EcA2 and a number of variants with amino acid replacements in the interior of the subunits 
or at interfaces between monomers. The results of these studies may help to construct EcA2 
variants with improved stability for applications in leukemia treatment  
The aim of the present study is to understand the molecular basis of the interactions 
between the subunits of EcA2. Moreover, we are interested in constructing EcA2 mutants 
with improved stability for possible application in leukemia treatment. To this end, site-
directed mutagenesis reaction was used to create many single mutants namely EcA2 
(Y176F), EcA2 (Y176S), EcA2 (D188N), and, EcA2 (D156N) at the dimer-dimer interface. 
On the basis of EcA2 (W66Y) (Derst et al., 1994), we have created two double mutants 
EcA2 (W66Y/Y176W), and EcA2 (W66Y/Y181W) on the dimer-dimer interface. To 
monitor the stability of EcA2 (WT) and its mutants we used guanidine hydrochloride 
(Gu.HCl) equilibrium denaturation, enzymatic activity assay, fluorescence and circular 
dichroism (CD) spectroscopy. Thermal unfolding of EcA2 and its mutants was examined by 
differential scanning calorimetry (DSC), CD, light scattering, and activity assays. For EcA2 
(WT) several basic parameters like pH-dependence and protein concentration dependence of 
denaturation, have been investigated, leading to a strong basis for the design of EcA2 
mutants with improved protein stability in the future.  
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2. Materials  
2.1 Apparatus   
Analytical balance      Mettler Toledo, Gießen 
Autoclave       Tuttnauer (Systec), Wettenberg 
CD spectrometer, AVIV 62-DS     Aviv Associates, Lakewood, NJ 
Centrifuge, Suprafuge 22     Heraeus, Osterode 
Centrifuge, Minifuge      Heraeus, Osterode 
Differential scanning microcalorimeter    Microcal, Amherst, MA 
DNA thermocycler      Biometra, Goettingen 
FPLC, Advanced Protein Purification 650E   Waters, Milford, USA 
FPLC, Variable wavelength Monitor    Knauer, Berlin 
Fraction collector, Frac-100     Amersham Pharmacia, Freiburg 
Heat bath, F3       Haake, Karlsruhe  
Heat incubation cupboard     Heraeus, Osterode 
Incubation shaker, Model G25    New Brunswick, Edison, USA 
Micropipettes       Gilson, France 
Millex GS; (0.25 µm)      Millipore, Bedford, USA 
Millex GS; (0.45 µm)      Millipore, Bedford, USA 
Nitrocellulose filter (0.2 and 0.45 µm)   Schleichernd Schuell, Dassel 
PD-10 desalting column     Amersham Pharmacia, Freiburg 
pH-meter, Toledo 340      Mettler, Gießen 
Refractometer       Carl-Zeiss, Jena 
Servapor 21mm, Dialysis membrane    Serva, Heidelberg 
Spectrofluorimeter, SFM 25     Kontron-instrument, Zeurich 
Spectrophotometer 551S     Perkin-Elmer, Langen  
Spectrophotometer, Ultrospec 3000    Amersham Pharmacia, Freiburg 
Speed-Vac concentrator     Savant, Martinsried, Germany 
Superdex 200 HR 10/30     Amersham Pharmacia, Freiburg 
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2.2 Chemicals 
Standard laboratory chemicals (usually of analytical grade) were supplied by Merck, Sigma, 
Serva, Roth, and used without further purification. 
8-Hydroxyquinoline      Sigma-Aldrich, Steinheim 
Acrylamide/Bisacrylamide (30%,0.8%)   Roth , Karlsruhe 
Agar-Agar       Fluka, Buchs 
Agarose       Sigma-Aldrich, Steinheim 
Ammoniumperoxodisulfate     Roth , Karlsruhe   
Ampicillin       Roth , Karlsruhe  
Bromophenol blue      Roth , Karlsruhe 
Calcium chloride      Fluka, Buchs 
Coomassie Brillant Blue     Serva, Heidelberg 
EDTA        Fluka, Buchs 
Ethanol p.A.       Sigma-Aldrich, Seelze 
Ethidium bromide      Roth, Karlsruhe  
Glycerol, 87%       Sigma-Aldrich, Seelze 
Glycine       Roth , Karlsruhe 
Guanidine hydrochloride     Fluka, Buchs 
HEPES       Sigma-Aldrich, Steinheim 
L-aspartic acid β-hydroxymate    Sigma-Aldrich, Steinheim 
Luria-Broth (LB) medium     Gibco, Karlsruhe 
MES        Sigma-Aldrich, Steinheim 
MOPS        Sigma-Aldrich, Steinheim 
N,N,N’,N’-Tetramethylenediamine     Serva, Heidelberg  
Piperazine       Fluka, Buchs 
Polybuffer 74       Amersham Pharmacia, Freiburg 
Polybuffer exchanger (PBE-94)    Amersham Pharmacia, Freiburg 
Sucrose       Roth, Karsruhe 
Serva Blue G       Serva, Heidelberg 
Sodium dodecylsulphate     Sigma-Aldrich, Seelze 
Trichloroacetic acid      Fluka, Buchs 
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Tris        Roth, Karlsruhe 
Xylenecyanol FF      Sigma-Aldrich, Steinheim 
β-Mercaptoethanol      Roth, Karlsruhe 
 
2.3 Kits, Enzymes, and Markers 
 
2.3.1 Kits 
QIAprep-spin, Plasmid Mini-Kit    Qiagen, Hilden 
QUIAEX Gel extraction kit     Qiagen, Hilden 
 
2.3.2 Enzymes 
EcoRI, Restriction endonuclease (10 U/µl)   Boehringer, Mannheim 
HindIII, Restriction endonuclease (10 U/µl)   Boehringer, Mannheim 
DpnI, Restriction endonuclease (10 U/µl)   Stratagen, Heidelberg 
PfuTurboTM, DNA-Polymerase    Stratagen, Heidelberg 
 
2.3.3 Markers for Gel electrophoresis and Gel filtration: 
Dalton Marker VII for SDS Gel electrophoresis  Sigma, Deisenhofen 
peqGold 1 kb DNA-Ladder     Peqlab, Erlangen 
peqGold 100 bp DNA-Ladder    Peqlab, Erlangen 
 
2.4 Oligonucleotides and Plasmids 
All synthetic nucleotides were synthesized by MWG Biotech (Ebersberg). 
 
2.4.1 Oligonucleotide primers for mutagenesis 
The following synthetic oligonucleotide primers were employed (mutagenic base changes are 
shown in underlined boldface): 
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Mutation ansB/Y176F 
MUTansB Y176F F: 5`-TCTGTTAACTTCGGTCCTCTG-3` 
MUTansB Y176F B:   3`-AGACAATTGAAGCCAGGAGAC-5` 
 
Mutation ansB/Y176S 
MUTansB Y176S F:   5‘-TCTGTTAACTCCGGTCCTCTG-3‘ 
MUTansB Y176S B:   3‘—AGACAATTGAGGCCAGGAGAC-5‘ 
 
Mutation ansB/Y176W #1 
MUTansB Y176W F:   5`-TCTGTTAACTGGGGTCCTCTGG-3` 
MUTansB Y176W B:  3`-AGACAATTGACCCCAGGAGACC-5` 
 
Mutation ansB/Y176W #2 
MUT Y176W F:        5`-ACCTTCAAGTCTGTTAAGTGGGGTTCCTCTGGGTTACATTC-3` 
MUT Y176W B:       3`-TGGAAGTTCAGACAATTCACCCCAAGGAGACCCAATGTAAG-5` 
 
Mutation ansB/Y181W 
MUTansB Y181W F:   5`-CCTCTGGGTTGGATTCACAACG-3` 
MUTansB Y181W B:  3`-GGAGAACCAACCTAAGTGTTGC-5` 
 
Mutation ansB/D188N 
MUTansB D188N F:  5`-CATTCACAACGGTAAGATTAACTACCAGCGTACCCCGGC-3` 
MUTansB D188N B:  3`-GCCGGGGTACGCTGGTAGTTAATCTTACCGTTGTGAATG-5` 
 
Mutation ansB/D156N 
MUTansB D156N F:  5`-TGAATGACACCGTGCTTAATGGCCGTGACGTCACC-3` 
MUTansB D156N B:  3`-GGTGACGTCACGGCCATTAAGCACGGTGTCATTCA-5` 
 
2.4.2 Oligonucleotides primers for sequencing 
ansB SEQ F1: 5`-AAC GCG GTA GTG ACC GCA GC-3` 
 
T7-Seq:  5‘-TAA TAC GAC TCA CTA TAG GG-3‘  
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2.4.3 Plasmids for EcA2 expression 
pTWE1        Laboratory 
pTWE/W66Y       Laboratory 
 
2.5 Microorganisms 
Microorganism Genotype Reference 
E. coli XL-1 blue 
recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac[F‘ proAB lacIq 
ZM15 Tn10(TetR)] 
Stratagen, Heidelberg 
E. coli BL21 (CU11783) 
F- gal met r- m- hsdS ansB- k lys 
placUV5-T7-Gen1 placq-lacI 
Harms et al., 1991 
 
Stocks of all microorganisms were prepared in sterile 87% glycerol and kept at -80 oC.  
 
2.6 Computer programs and Internet links 
Biotools        http://www.mbshortcuts.com/biotools 
Crystal structure     http://www.rcsb.org 
PicoLog for Windows     Pico Technology, UK 
PowerPoint      Microsoft 
Sigmaplot      Jandel Scientific 
SPDB-Viewer      http://www.expasy.ch/spdbv 
WebLab Viewer pro     Accelrys Inc. 
Windows       Microsoft 
Word       Microsoft 
 
 
 
 
                                                                                                           Chapter 3. Methods 
 20 
3. Methods 
3.1 General precautions 
All potentially harmful operation were carried out in restricted areas. Media, 
solutions, and instruments required for molecular biology were autoclaved to sterilize them. 
Temperature-sensitive solutions were sterilized by means of sterile filtration through 0.45 
µM filters. All bacterial waste was decontaminated by autoclaving for a minimum of 30 min 
at 121 oC or higher before disposal. Waste containing ethidium bromide was disposed of 
separately. All dangerous chemicals were handled using safety glasses and gloves. 
 
3.2 Bacterial growth 
3.2.1 Medium 
 
LB-medium LB Medium 25 g/l composed of: 
Tryptone 10 g/l  
Yeast extract 5 g/l  
NaCl 10g/l  
pH 7.5            
 
10 g tryptone, 5 g yeast extract, and 10 g NaCl were dissolved in 800 ml dH2O. pH 
was adjust to 7.0 with 1 N NaOH and the volume was  adjusted to 1 liter with dH2O. This 
medium was sterilized by autoclaving. 
 
LBAmp-Plates LB medium 25g/l 
Agar 15 g/l 
pH 7.5 
Ampicillin 100 mg/l 
 
To 1 liter LB medium 1.5 % agar was added. After autoclaving, the medium was 
cooled in a 55 °C water bath. Before plating out, 100 mg/ml ampicillin was added. Per small 
agar plate (9 cm diameter) ca. 25 ml medium was poured and allowed to cool. LBAmp plates 
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were kept at room temperature overnight and stored at 4 °C.  
 
3.2.2 Storage and revival of bacterial cultures 
 
10 µl of frozen cells from a 87% glycerol stock was inoculated into 5 ml of LB 
medium. E. coli cultures were grown overnight with shaking at 37 oC. A loopful of culture 
was streaked on LB plates and the plates were incubated overnight at 37 oC. The colonies 
formed could be used up to 1 month when kept at 4 oC. For longer storage, a fresh culture of 
exponentially growing cells was mixed with sterile 87% glycerol in an 1:1 ratio (v/v) and 
stored at -80 oC. 
 
3.3 Preparation of competent cells  
 
Transformation buffer TFB-1 100 mM RbCl 
50 mM MnCl2 
30 mM CH3COOK  
10 mM CaCl2 
15 % Glycerol 
Adjust to pH = 5.8 with 0.2 M  CH3COOH 
Sterilised by filtration 
Transformation buffer TFB-2 10 mM MOPS 
10 mM RbCl 
75 mM CaCl2 
Adjust to pH = 7.0 with NaOH  
Sterilised by filtration 
 
100 ml of LB medium was inoculated with 1 ml of a fresh overnight culture of E. coli 
XL-1 blue or BL21, and growth continued with shaking at 37°C to an OD550 nm of 0.4-0.5. 
Bacterial cells were transferred to a sterile, ice-cold 50-ml polypropylene tube and the cells 
were recovered by centrifugation at 5000 x g for 10 min at 4 oC. The medium was decanted 
and the cell pellet was resuspended by swirling in 15 ml sterile TFB-1 and incubated in ice 
for 15 min at 4 oC. After incubation, cells were spun down at 5000 x g for 5 min at 4 oC. The 
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pellet was resuspended in 2 ml of TFB-2. Aliquotes of this cell suspension were kept at -80 
oC up to one year. [Dager and Ehrlich, 1979; Hanahan und Meselson 1983] 
 
3.4 Preparation of Plasmid-DNA 
The QIAprep-spin plasmid kit (250) from QIAGEN was used for the preparation of 
double-stranded DNA. 3 ml of LBA medium was inoculated with 10 µl glycerol stock of 
transformed E. coli cells with shaking for overnight at 37°C. This culture was centrifuged at 
4°C for 10 min at 14,000 x g to isolate the cell pellet. 
 
Reagents  
P1      
P2      
N3      
PB      
PE       
EB (Elution buffer)    
Cell resuspension buffer  
Cell lysis buffer  
Neutralization buffer  
Wash buffer 
Wash buffer 
10 mM Tris/HCl, pH=8.5 
 
The pelleted bacterial cells were resuspended in 250 µl of buffer P1. After that, 250 
µl of SDS-containing lysis buffer P2 was added and mixed with the cell pellets by inverting 
4-6 times. 350 µl of chilled neutralization buffer N3 was added to the lysate and mixed by 
gentle inversion to precipitate the cell components. The precipitate was removed by 
centrifugation at 4°C for 10 min at 14,000 x g and the supernatant was discarded. A 
QIAprep-spin column was placed in a micro centrifuge tube and the supernatant was applied 
to the column. After centrifugation for 1 min, the fluid in the spin column was drained into 
the micro centrifuge tube, while the plasmid DNA from the supernatant was bound to the 
column material. The column was then washed by adding 500 µl of PB buffer and again 
centrifuged for 1 min. The flow-through was discarded. The column was washed another 
time with 750 µl of PE buffer as above. Finally, the bound DNA was eluted with 100 µl of 
TE buffer by centrifugation. 
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3.5 Determination of DNA concentration 
 
The concentration of DNA was estimated according to the following equation: 
 
µg DNA = A260 * 50 * volume of total solution (ml) * dilution ratio 
 
  
3.6 DNA Sequencing 
 
For sequencing, template DNA was diluted to concentrations of 100-200 ng/µl and 
dried in the Speed-Vac for 1 h. Plasmid DNA was sent to MWG Biotech (Ebersberg) for 
primer synthesis and sequencing. 
 
3.7 Mutagenesis [Stratagene, 1992] 
 
The QuikChange site-directed mutagenesis kit is used to create point mutations, 
switch amino acids, and delete or insert single or multiple amino acids. The QuikChange site-
directed mutagenesis method uses PfuTurbo® DNA polymerase and a temperature cycler. 
PfuTurbo DNA polymerase replicates both plasmid strands with high fidelity and without 
displacing the mutant oligonucleotide primers. The basic procedure utilizes a supercoiled 
double-stranded DNA (dsDNA) vector with an insert of interest and two synthetic 
oligonucleotide primers containing the desired mutation. The oligonucleotide primers, each 
complementary to opposite strands of the vector, are extended during temperature cycling by 
PfuTurbo DNA polymerase. Incorporation of the oligonucleotide primers generates a 
mutated plasmid containing staggered nicks. Following temperature cycling, the product is 
treated with Dpn I. The Dpn I endonuclease is specific for methylated and hemi-methylated 
DNA and is used to digest the parental DNA template and to select for mutation-containing 
synthesized DNA (Nelson et al., 1992). DNA isolated from almost all E. coli strains is 
methylated and therefore susceptible to Dpn I digestion. The nicked vector DNA containing 
the desired mutations is then transformed into XL1-Blue supercompetent cells.  
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3.7.1 Mutagenesis-PCR 
 
 
PfuTurboTM DNA-Polymerase 2.5 U/µl 
Polymerase-Buffer 10 x  
Template DNA Miniprep 1:20 
Primer A 10 pmol/µl 
Primer B 10 pmol/µl 
DNTP-Mix dATP, dGTP, dTTP, dCTP) each 10 mM 
DMSO-Solution 50 % DMSO 
 
Sample reactions were  prepared in 50 µl volumes as indicated below : 
5 µl 10 x Polymerase-Buffer 
1 µl Template DNA (ca. 5 – 50 ng) 
1.25 µl Primer A  (125 ng) 
1.25 µl Primer B  (125 ng) 
1 µl dNTP-Mix 10 mM each dNTP 
2 µl DMSO 
38.5 µl H2O 
Before starting the PCR, 1 µl PfuTurboTM was added in the reaction mixture. Cycling 
Parameters for the QuikChange Site-Directed Mutagenesis Method were as listed below: 
 
Steps    
1 30 Sec 95 °C 1 x 
2 30 Sec 95 °C 
3 1 min 55 °C 
4 12 min 68 °C 
 
 
15 x 
5  4 °C  
 
3.7.2 DpnI Digestion of the Amplification Products 
 
DpnI 10 U/µl 
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1 µl of the DpnI restriction enzyme (10 U/µl) was directly added to each 
amplification reaction and incubated at 37 °C for 1 h.  DpnI-treated DNA was transformed in 
E. coli XL-1 blue competent cells.  
 
3.7.3 Transformation of supercompetent E. coli XL-1 blue cells 
 
5-10 µl of the DpnI-treated DNA was mixed with 100 µl of competent E. coli XL-1 
blue cells and incubated in ice for 15 min. The cells were then heated in a water bath (42 °C) 
for 60 s and immediately cooled down in ice for 5 min. 800 µl of LB-medium was added to 
the competent cells. The cells were incubated at 37 °C for 30-45 min. After incubation, the 
cells suspension was spread on LBA plates with a sterile glass spreader. After drying up 
excess liquid, the plates were incubated at 37°C for overnight. 5 ml of LBA medium was 
inoculated with a single clone on agar plates and incubated overnight at 37 °C with shaking. 
Plasmid DNA was prepared from overnight culture and checked for sequencing as in section 
3.4.  
 
3.8 Analytical DNA digestion by restriction endonucleases 
 
 
Buffer B 10 mM Tris/HCl, pH 8.0 
100 mM NaCl 
5 mM MgCl2 
1 mM 2-mercaptoethanol 
EcoRI 10 U/µl 
HindIII 10 U/µl 
 
 
5 – 10 µl Mini-Plasmid-Preparation was added with 
 2.0 µl Buffer B 
 0.7 µl EcoRI 
 0.7 µl HindIII 
and incubated for 2 h at 37  °C. DNA fragment digested with EcoRI/HindIII can be identified 
by agarose gel electrophoresis (section 3.9). Insert DNA was detected as 1.4 kb fragments 
and plasmid DNA (pT7-7) was detected at 2.5 kb fragment.  
                                                                                                           Chapter 3. Methods 
 26 
3.9 Agarose gel electrophoresis (Maniatis et al., 1982) 
 In agarose gels, DNA fragments can be separated from each other according to their 
size. The electrophoretic mobility of DNA fragments is inversely related to their length, as 
each nucleotide in a nucleic acid molecule carries a single negative charge. 
 
Electrode buffer, 1 x TAE  1 mM EDTA 
20 mM Tris/HAc; pH 8.0 
Gel-Solution 1 % (w/v) agarose 
10-4 % ethidium bromide 
in 1 x TAE-Buffer 
Gel loading dye solution 10 x 25 mg bromophenol blue 
25 mg xylenecyanol 
5 ml 85 % glycerol 
2 ml 50 x TAE 
3 ml dd H2O 
 
DNA bands can be detected by staining with ethidium bromide. The dye ethidium 
bromide fluoresces under ultravoilet light when bound to DNA.  
The gel matrix was prepared as follows: 0.4 g of agarose was dissolved in 40 ml of 
1xTAE buffer by boiling. 5 µl of ethidium bromide was added to this gel solution and poured 
into the corresponding gel apparatus. After solidification of the gel, 800 ml electrode buffer 
was poured into the apparatus to cover the gel surface. 20 µl of DNA solution was mixed 
with 3 µl of dye solution and placed in the wells of the gel. After that, the DNA was 
separated for 45 min at the voltage of 100 V. The DNA bands in the gel were then visualized 
on a transilluminator using UV light (365 nm). 
 
3.10 Transformation of supercompetent E. coli BL21 
5-10 µl of the BL21/pTWE* was mixed with 100 µl of competent E. coli BL21 
cells and incubated in ice for 15 min. The cells were then heated in a water bath (42 °C) for 
60 s and immediately cooled down in ice for 5 min. 800 µl of LB-medium was added to the 
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competent cells. The cells were incubated at 37 °C for 30-45 min. After incubation, the cells 
suspension was spread on LBA plates with a sterile glass spreader. After drying up excess 
liquid, the plates were incubated at 37 °C overnight. 5 ml of LBA medium was inoculated 
with a single clone on agar plates and incubated overnight at 37 °C with shaking. Plasmid 
DNA was prepared from overnight culture and checked for sequencing as in section 3.4.  
 
3.11 Determination of protein concentration 
3.11.1 UV Spectroscopy (Homer and Allsopp, 1976) 
Asparaginase concentrations were determined from UV spectra by assuming an 
absorption of A(1%)280 = 7.7 (i. e., a 10 mg/ml solution has an A280=7.7). 
 
3.11.2 Bradford method (Bradford, 1976) 
 
Bradford-Reagent 
 
10 % (w/v) Serva Blue G 
10 % (v/v) 85 % phosphoric acid 
5 % (v/v) 95 % ethanol 
BSA-Standards 25/50/100/200/400 µg/ml BSA in ddH2O. 
 
For quantitative protein determination, 1 ml of 1 M NaOH was added to 20 ml of 
Bradford-Reagent. 100 µl of protein solution was mixed with 1 ml Bradford reagent and 
incubated at room temperature for 20 min. Absorption was measured at 595 nm against a 
blank (100 µl H2O, 5 ml Bradford reagent). For the standard curve, 10 sample solutions of 
diluted ovalbumin were measured in the same way. 
 
3.12 Expression of EcA2 (Harms et al., 1991; Wehner, 1993) 
 
3.12.1 Bacterial cultures 
100 ml of LBA medium was inoculated with 10 µl of a BL21/pTWE* glycerol 
culture and incubated overnight at 37 °C with shaking. After that, the culture was transferred 
to 1 liter of LBA medium and cells were grown for further 6 h.  
                                                                                                           Chapter 3. Methods 
 28 
3.12.2 Osmotic shock 
 
Spheroblast buffer       100 mM Tris/HCl; pH 8.5 
0.5 M Sucrose 
0.5 mM EDTA 
 
The bacterial cells from 2 l culture were collected by centrifugation at 1,800 x g for 
15 min at 4 °C. The cells pellet was suspended in 200 ml of spheroblast buffer by vortexing. 
These resuspended cells were incubated in ice for 10 min. After that, the suspension was 
centrifuged at 4 °C for 20 min at 6,000 x g. The supernatant was discarded and the pellet 
retained.  
This pellet was resuspended in 50 ml of ice-cold water using a vortex and then 
incubated in ice for 15-20 min. The periplasmic proteins were separated from the cells by 
centrifugation at 10,000 x g for 30 min at 4 °C. The enzyme-containing supernatant was 
collected, taking care to avoid contamination with bacterial cells. 
 
3.12.3 Precipitation with ammonium sulphate 
The supernatant was first brought to 50% ammonium sulphate (29.5 g/100 ml) 
saturation within 1 h at 4 °C. The precipitation was collected by centrifugation at 15,000 x g 
for 15 min at 4 °C. After that, the supernatant was brought to 95% saturation by further 
addition of ammonium sulphate (27.2 g/100ml) and kept at 4 °C before chromatofocusing. 
 
3.12.4 Chromatofocusing (Sluyterman and Elgersma, 1978, Sluyterman and Wijdenes, 
1978) 
 
Column material  PBETM94 Polybuffer exchanger 
Starting buffer 25 mM piperazine/HCl; pH 5.5 
Elution buffer 0.1 x Polybuffer® 75/HCl; pH 4.0 
 
The ammonium sulphate precipitate was centrifuged at 15,000 x g, 4 °C for 15 min. 
The pellet was dissolved in the minimum volume of starting buffer and dialysed against 2x 
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500 ml of the same buffer to remove ammonium sulphate. The resulting solution was 
centrifuged to remove impurities before loading to the column. 
The chromatofocusing column (250 x 10 mm) containing polybuffer exchanger was 
equilibrated with 250 ml of starting buffer. Before loading the sample, the column was eluted 
with 2 ml of polybuffer. After loading the protein solution, the flow of elution buffer was 
adjusted to a velocity of 20-30 ml/h. 90 fractions of 1.5-2.5 ml were collected. After each 
run, the column was washed with 1.0 M NaCl. 
All fractions were analyzed for protein concentration (section 3.11.1), pH values and 
asparaginase activity (section 3.16.3). In addition, protein purification was checked by SDS-
PAGE (section 3.14). The fractions of interest were collected according to the elution 
profiles and the protein was precipitated by adding ammonium sulphate to 95% saturation to 
remove the polybuffer. The precipitates could be stored at 4 °C for prolonged times before 
use. 
 
3.13 Preparative Gel Filtration 
The aim of gel filtration was to completely separate protein from remaining 
polybuffer. Gel filtration separates protein molecules according to their size. Large molecules 
are unable to penetrate the pores of the cross-linked polymer and are eluted from a Sephacryl 
column ahead of small molecules. The molecular weight of asparaginases is 144,000, so gel 
filtration is the most suitable method to remove polybuffer. 
 
Gel matrix Sephacryl® S-300 
Starting and elution buffer 100 mM Tris/HCl; pH 7.0 
 
Enzyme solutions in 95% ammonium sulphate were centrifuged to get a pellet which 
was dissolved in the minimum volume (ca. 1 ml) of starting buffer and dialyzed against the 
same buffer (2x 500 ml). The protein solution was filtered through a 0.45 µm nitrocellulose 
membrane and degassed by sonication. The column (450 mm x 20 mm) was equilibrated 
with starting buffer. After dialysis, the enzyme sample was loaded on the column. The 
elution of the sample was carried out at a velocity of 12 ml/h. After determination of protein 
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concentration (section 3.11.1) and asparaginase activity (Section 3.16.3), the fractions of 
interest were collected for protein precipitation with ammonium sulphate (32.5 g/50 ml) and 
stored at 4 oC. 
 
3.14 SDS polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1978, 
Biorad Instruction Manual, 1987) 
Proteins can be separated on the basis of their mass by SDS polyacrylamide gel 
electrophoresis under denaturing conditions. Sodium dodecyl sulphate (SDS), an anionic 
detergent disrupts nearly all noncovalent interactions in native proteins. Mercaptoethanol 
reduces the disulphide bonds of the protein.  
 
Acrylamide solution 30 % acrylamide 
0,8 % bisacrylamide 
Separating gel buffer 1.5 M Tris/HCl; pH 8,8 
Stacking gel buffer 0.5 M Tris/HCl; pH6,8 
Sample loading buffer 0.1 M Tris/HCl; pH 6,8 
2 % SDS 
3 % mercaptoethanol 
10 % glycerol 
0.01 % (w/v) bromophenol blue 
10 x running buffer 250 mM Tris 
1.9 M glycine 
35 mM SDS 
 
Composition of the gel solution 
 
 
Gel solution:   
Separating gel: 
(15 % Acrylamide) 
Stacking gel : 
(4.5 % Acrylamide) 
 
4.000 µl 650 µl acrylamide solution 
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2.500 µl ----- separating gel buffer 
 
----- 1.250 µl stacking gel buffer 
100 µl 50 µl 10 % SDS 
3.350 µl 3.000 µl dd H2O  
50 µl 25 µl 10 % APS 
10 µl 5 µl TEMED 
 
On the average one SDS molecule binds for every two amino acids. Therefore, the 
complexes of SDS with the denatured protein carry a large net negative charge and migrate 
towards the anode. The velocity of migration of SDS-protein complexes is approximately 
inversely proportional to the mass of the protein. 
The protein solution was mixed with sample loading buffer in (1:1) ratio (v/v) and 
placed in boiling water for 3 min for denaturation. 3.5 ml of separating gel solution was 
added to the spaces between two glass plates in the gel apparatus. Stacking gel solution was 
added immediately to the top of the separating gel solution layer and the comb was placed in 
the stacking gel solution. About 1 h later the gel had polymerized. Before sample loading 
into the wells, running buffer was filled up to cover the gel. The comb was removed carefully 
and the wells were cleaned up with running buffer to remove the gel pieces. The samples 
were then loaded into the wells under the running buffer with an Eppendorf pipette. 
Separation of the proteins was carried out at the voltage of  80 V for  15 min. Once protein 
entered into the separation gel the current was set at 200 V and allow to run for an additional 
45 min. Finally, the proteins in the gel were visualized by staining with coomassie blue. 
 
3.15 Coomassie staining 
 
Staining solution 45 % methanol 
10 % acetic acid 
0.1 % (w/v) Coomassie Brillant Blue 
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De-staining solution 45 % methanol 
10 % acetic acid 
   
After electrophoresis, the separating gel was immersed in the staining solution for 15 
min at 50 °C. The gel was then rinsed with water. After that, it was de-stained at 50 °C for  
1-2 h. The de-staining solution has to be changed more than 2 times during the process. 
Before drying the gel it was washed again with water then dried at 70 °C for 90 min under 
vacuum.  
 
3.16  Asparaginase assays 
Asparaginase activity towards L-asparagine can be measured by monitoring the 
decrease of the amide band absorption at 225 nm. This method, although convenient, is 
rather insensitive and subject to systematic error. Therefore, in this work discontinous assays 
were used for kinetic studies.  
 
3.16.1 Assay of NH3 with Nessler's reagent 
The hydrolysis of L-asparagine was examined by ammonia determination with Nessler’s 
reagent. Immediately after addition of the reagent, the absorption was measured at 480 nm. 
The absorption coefficient of the product is A480=1130+50 M-1cm-1.  
 
3.16.2 Principle of the AHA assay (Frear and Burrel, 1955, Derst et al., 1994) 
 The Nessler method is not sensitive enough to accurately determine Km values below 
1 mM. Therefore the discontinous AHA assay was used for kinetic studies. EcA2 has 
comparable activities towards its natural substrate, L-asparagine and L-aspartic acid β-
hydroxamate (AHA). The assay is based on the reaction of hydroxylamine liberated from 
AHA with 8-hydroxyquinoline (oxin) at high pH. The resulting green oxindol dye has an 
absorption coefficient of about 1.75x 104 M-1cm-1 at 705 nm and is thus detectable with high 
sensitivity. 
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In this work, L-AHA was used as the substrate for activity profile and kinetic studies. 
For activity profiles, relative activities of the enzyme (mU) and for enzyme kinetics, specific 
activities (mU/mg) were calculated. 1 unit (U) of asparaginase activity is the amount of 
enzyme that catalyze the hydrolysis of 1 µmol substrate in 1 min at 25 °C. 
 
3.16.3 Activity profile after chromatofocusing 
 
Reaction buffer 50 mM MES; pH 5,0 
Substrate solution 20 mM AHA in 50 mM MES, pH 5.0 
Oxin solution 25 % (v/v) 2 % 8-hydroxyquinoline in 
ethanol 
75 % 1 M Na2CO3 
Stop solution 12 % TCA 
 
10 µl of enzyme solution from each fraction after chromatofocusing was added to 180 
µl of reaction buffer. 10 µl of AHA solution was added to start the reaction and incubated for 
1 min at room temperature. 50 µl of 12% (w/v) TCA solution was added to stop the reaction. 
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After addition of 1000 µl of oxin/Na2CO3, the samples were heated in water bath (100 °C) for 
1 min to complete the reaction. The samples were measured against the blank without 
enzyme solution at 705 nm after cooling the samples to room temperature.  
 
3.16.4 Kinetic Characterization 
 
Oxin solution 25 % (v/v) 2 % 8- hydroxyquinoline in 
ethanol 
75 % 1 M Na2CO3 
Stop solution 12 % TCA 
Reaction buffer 50 mM Tris/HCl, pH 8.0 
 
1 ml enzyme suspension in 95% ammonium sulphate was centrifuged for 10 min at  
4 °C.   The enzyme pellet was dissolved in 1 ml of 50 mM Tris/HCl (pH=7.0) and dialysed 
against the same buffer for 5 h. The resulting solution was centrifuged for 10 min to remove 
impurities. The protein concentration was determined by UV spectroscopy, and the protein 
concentration adjusted to 0.30 mg/ml or less.   
Depending on the enzyme concentration and activity, 20-100 µl of enzyme was added 
to 1 ml of a substrate solution (25 µM-1.5 mM AHA in 50 mM Tris/HCl; pH 8.0). The 
assays were incubated for 1-30 min at 25 °C, depending on activity. At regular intervals (at 
least 5 times), 100 µl-aliquots were removed and added to microcentrifuge tubes containing 
25 µl 12 % (w/v) TCA to stop the reaction. 1 ml of colour reagent (oxin/Na2CO3) was added 
to each tube. All microcentrifuge tubes were closed tightly and heated in boiling water bath 
for 1 min to develop the color. After allowing to cool for 10 min, the absorption was read at 
705 nm.  
Initial rates of AHA hydrolysis were calculated from parabolic fits to plots of A705 vs. 
time. The kinetic parameters Vmax and Km were calculated from non-linear fits of the 
Michaelis-Menten equation to the data using SigmaPlot. 
 
 
 Vmax  is the maximum velocity and Km is the Michaelis-Menten constant. Vmax  is 
given as units/mg. One asparaginase unit will liberate 1.0 µmol of NH3 or NH2OH (from L-
Vmax . [S]
Km + [S]V =
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asparaginase or L-asparagine ß-hydroxymate) per min at a given pH at 25 °C. Km is the 
substrate concentration at half-maximal velocity. In the simplest case, it corresponds to the 
dissociation constant of the ES complex. 
 
3.17 Determination of conformational stability 
3.17.1 Chemical denaturation (Pace et al., 1989: Shirley, 1992) 
The stability of the active asparaginase tetramer was monitored by measurements of 
its tryptophan fluorescence at various concentrations of guanidine/HCl. In a hydrophobic 
environment, such as in the interior of a folded protein, tryptophan fluorescence emission 
occurs at shorter wavelength of 320-330 nm. During denaturation e.g. by guanidine/HCl, a 
strong decrease in tryptophan fluorescence is produced by the transfer of a residue 
(tryptophan) from the protein interior (hydrophobic environment) to aqueous environment 
with a concomitant red shift of the emission maximum to about 350 nm (Schmid, 1989). 
 
Buffer 50 mM Tris/HCl; pH 8,0 
Denaturant stock solution 3 M Gu/HCl 
 
Enzyme suspension in 95% ammonium sulphate solution were centrifuged for 10 min 
and the pellet dissolved in 1 ml 50 mM Tris/HCl (pH=8.0). The resulting enzyme solution 
was dialysed against 50 mM Tris/HCl (pH=8.0) overnight to remove residual ammonium 
sulphate and bound aspartate. After that, the enzyme solution was centrifuged for 10 min to 
remove impurities and diluted to about 1 mg/ml (A280=0.77). 
 The denaturant solution, double-distilled water, the buffer and the enzyme solution 
were filtered through 1.2 µm nitrocellulose filters to remove small particles which disturb the 
fluorescence measurements by light scattering. 
Samples containing different concentration of the denaturant guanidine/HCl were 
prepared by mixing 50 µl enzyme solution with appropriate volumes of 3 M guanidine/HCl, 
1 M Hepes stock solution (pH=8.0) and water. The resulting sample had a buffer 
concentration of 50 mM and a volume of 1 ml. 30 such samples were prepared. The first 
sample solution contained no denaturant, while the last one contained 1.5-2.0 M 
guanidine/HCl. 
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 The mixture was incubated at 25 °C  for 3 h to allow for equilibration. During the 
incubation period, the refractive index of each sample was measured with a refractometer to 
determine the exact guanidine/HCl concentration. Then fluorescence emission spectra were 
recorded in a SFM 25 spectrofluorimeter (Biotek). All samples were excited at 285 nm and 
their emission was measured between 300 to 400 nm.  
 
3.17.1.1 Evaluation of denaturation experiments (Pace et al., 1989) 
 The actual denaturant concentration of each sample was calculated from its refractive 
index n according to Nozaki (Nozaki, 1972). 
 
III.1 ∆n = n(guanidine/HCl) – n(H2O) 
III.2 [guanidine/HCl] = 57.147 (∆n) + 38.68 (∆n)2 - 91.6 (∆n)3 
 
The fraction of unfolded protein (fd) as a function of Gu.HCl was calculated as 
described below. From these data the conformational stability in water, G(H2O) and a 
measure of the dependence of G on denaturant concentration (m) were estimated. 
Gu.HCl (M)
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f d
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pd pn - pd
pn - I
 pn - I
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=
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Figure 3.1 Sketch of a protein unfolding transition, as measured by fluorescence spectroscopy, pn and 
pd are the values of folded and unfolded forms, respectively, which both depend upon the 
concentration of denaturatnt (Gu.HCl). The fluorescence intensity is shown as a function of 
denaturant concentration.  
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For some EcA2 variants, the denaturation curves (fluorescence versus denaturant 
concentration) obeyed a simple two state model (Pace, 1989; see figure 3.1 ) 
 
 
 
By assuming a two state mechanism, only the folded and unfolded forms of the 
protein are presented at significant concentrations and  
1=+ dn ff          (1) 
Where fn and fd represents the fractions of total protein in the folded and unfolded 
conformations, respectively. The value at any point on the transition curve is given by   
ddnn fpfpI ⋅+⋅=         (2) 
Where I is any observable parameters chosen to follow unfolding, and pn and pd 
represents the values of I characteristic of the folded and unfolded protein. The values of pn 
and pd for any point in the transition region are obtained by extrapolation of the pre- and post-
transition baselines, which is generally achieved by a least-square analysis (Pace et al., 
1989). Combining Eqs. 1 and 2 yields: 
 
nnnn bImp +⋅=  (native fraction)     (3) 
 dddd bImp +⋅=  (denatured fraction)     (4)  
The equilibrium constant can be calculated by using following equation: 
n
d
D f
fK =          (5) 
 Combining Eqs. 1, 2, and 5 yields apparent fraction of denatured protein:   
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==         (7) 
 The free energy change in the absence of denaturant GH2O for the folding-unfolding 
reaction can be calculated using: 
Folded (native)                       Unfolded (denatured)
KD
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DKRTG ln⋅−=∆ ,        (8)
 ][2 DmGG OHD ⋅−∆=∆        (9) 
Where GD is the free energy change at the denaturant concentration [D], R is the gas 
constantn and T is the absolute temperature (oK). Combining Eqs. 8 and 9 yields:  
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 Equation 9 was fit to I vs. [D] data to estimate values of GH2O and m. The parameter 
m is a measure of the dependence of G on denaturant concentration.  
 
For 3-state model    
 1=+ + uin fff        (12) 
 Where fi is the fractions of total protein in intermediate form. The observed value at 
any point on the transitions curve is given by  
 ddiinn fpfpfpDI ⋅+⋅+⋅=])([       (13) 
 Where I[D] is the fluorescence intensity chosen to follow unfolding at particular 
denaturant concentration. pn , pd and pi represents the values of I[D] characteristic of the 
native, dissociated and completely dissociated protein. The relative concentrations are 
calculated as:    
211
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K
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 KD1 and KD2 are the equilibrium constants for the first and second dissociation 
equilibrium. They can be calculated from the equations: 
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1][1
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 s1 and o1 as well as s2 and o2 are for the range of the transition phase. 
 xxOH oTRG ⋅⋅−=∆ 2        (19) 
 xx sRTm ⋅=          (20) 
 Where GH2Ox is the dissociation enthalpies in respective phase in the absence of 
denaturant and m is a measure of the dependence of G on denaturant concentration in 
respective phase.  
 In the 3-state model we can use the Eqs. 14 to 18 to calculate the value of GH2O x   
and m values. Half denaturation point [ D]1/2, i.e. the Denaturant concentration, at  which 
both phases are present at same portions can be calculated by using following equation: 
       
 
m
GD OH 22/1][
∆
−=         (21) 
 
 
3.17.2 Thermal denaturation 
 
To understand the effects of temperature on the protein stability, thermal denaturation 
studies were carried out with the wild type and mutant EcA2. The residual activity of enzyme 
after heat treatment was estimated according to the previously described method (Derst, C., 
Thesis, 1995). 
 
Reagents  
Buffer  50 mM Hepes (pH = 8.0) 
Substrates 1 mM AHA (pH = 5.0) in the above buffer 
TCA solution 12% (w/v) trichloroacetic acid in water 
Oxin/Na2CO3 (1:3) (v/v) 2% (w/v) 8-hydroxyquinoline in ethanol 
and 1 M Na2CO3 
Mineral oil  
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An enyzme suspension in ammonium sulphate was centrifuged for 10 min and the 
enzyme pellet was dissolved in 50 mM Hepes (pH=8.0). The solution was first dialyzed 
against 50 mM Hepes (pH=8.0) overnight to remove residual ammonium sulphate and bound 
aspartate. After that, the enzyme solution was centrifuged for 10 min to remove impurities. 
The enzyme concentration was determined by UV spectroscopy. Concentration of 0.25-0.30 
mg/ml were suitable for thermal denaturation.  
 100 µl of the above enzyme solution was placed into each one of the three reaction 
cups, and 2 drops of mineral oil were added. The layer of oil protects the enzyme solution 
from quick evaporation. The reaction cups with enzyme solution were placed at the 
thermocycler and the temperature gradient was programmed as follows:  
   
First cycle 25 °C 1 min 
Second cycle 25 °C - 80 °C  45.8 min 
     
The enzyme solution was first pre-warmed for 1 min at 25 °C and then slowly heated 
to 85 °C with a change of temperature of 1.2 °C/min. 10 µl of enzyme solution was removed 
every minute and immediately mixed with 200 µl of 1 mM AHA substrate solution (working 
pH was same as that of the dialysis buffer). After incubation of solution for 1 min, 50 µl of 
12% (w/v) TCA was added to stop the reaction. 500 µl of oxin/ Na2CO3 solution was added 
to each cups and heated in boiling water bath (100 °C) for 1 min to develop the colour. After 
cooling down for 10 min, the absorption was measured at 705 nm. From these data, relative 
activities (in mU) were calculated and activity was plotted vs. temperature (°C).  
 
3.17.3 Renaturation after thermal unfolding 
  
First cycle 25 °C 1 min 
Second cycle 60 °C  30 min 
Third cycle 25 °C 29.2 min 
 
            The enzyme solution was first pre-warmed for 1 min at 25 °C and then heated to  
60 °C for 30 min for denaturation of enzyme. The enzyme solution was then slowly cooled to 
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25 °C with a change of temperature of 1.2 °C/min. 10 µl of enzyme solution was removed 
every minute and immediately mixed with 200 µl of 1 mM AHA substrate solution. All 
samples were analysed for asparaginase activity as described in section 3.16.3.  
 
3.18 Analytical Gel filtration 
 
Column Superdex 200 10/30 
Starting and Elution buffer 50 mM Hepes/HCl; pH 8.0 
X M Gu/HCl 
Gu.HCl-Buffer 3.0 M Gu/HCl 
50 mM Hepes/HCl; pH 8.0 
Marker proteins: 
Cytochrome c (horse heart) 
Carbonic Anhydrase (bovine blood) 
Albumin (bovine serum) 
Alcohol-Dehydrogenase (yeast) 
-Amylase (sweet potato) 
Dextrane Blue 
 
12,4 kDa 
29 kDa 
66 kDa 
150 kDa 
200 kDa 
2.000 kDa 
 
The column was connected to an Äkta Explorer 100 FPLC system (Amersham 
Pharmacia Biotech). It was pre-equilibrated with different concentration of GuCl in 50 mM 
Hepes buffer of pH 8.0 at a flow rate of 0.5 ml/min. Protein samples (1 mg/ml) were 
incubated for 3 h with different concentrations of Gu/HCl at room temperature and 
centrifuged at 15000 x g for 10 min to remove insoluble material and loaded on the column 
through a 100 µl loop. Elution at a flow rate of 0.5 ml/min was monitored by absorbance at 
280 nm.  
 
3.19 Sedimentation equilibrium centrifugation 
Sedimentation equilibrium ultracentrifugation was performed in a high-speed air-
turbine centrifuge (Airfuge, Beckman; cf. Bothwell et al., 1978). Carbonic anhydrase (29 
kDa), Ovaalbumin (45 kDa), Bovine serum albumin (66 kDa), Phosphorylase B (95 kDa) 
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were employed as molecular weight standards. The final solutions in 300 l volume were 
prepared by mixing 300 g protein and different concentration of Gu.HCl (0 M-1.5 M) with 
270 l  of a 5 mg/ml Dextran-100 solution, each dissolved in 50 mM Hepes pH 8.0 (dextran 
is routinely included to stabilize the equilibrium distribution of the protein during 
deceleration of the rotor, Bothwell et al., 1978). 200 l samples in 300-l centrifuge tubes 
were spun in the “Airfuge” at room emperature for 16 hr at 60,000 rpm, whereas the 100 l 
of control solutions were kept outside the centrifuge. After centrifugation, the upper 20 l of 
samples and controls were carefully withdrawn and assayed for protein concentration by 
using Bradford assay (Section 3.11.2). 
From the analytical data, the protein fraction depletion F (F = A/Ao) was calculated, 
where A is protein concentration in the sample and Ao is the corresponding value in the 
control. Calibration curves (log F of standard proteins versus their molecular mass were used 
to estimate the average mass of the catalytically active forms of EcA2 at different Gu.HCl 
concentrations. 
 
3.20 Circular Dichroism (CD) Spectroscopy and Light Scattering 
 A plane-polarized light beam can be represented as a sum of right- and left- circularly 
polarized beams of equal intensity. When plane-polarized light passes through a chiral 
medium, differential absorption of the two circular components converts the plane polarized 
light into elliptically polarized light. The ellipticity is the angle , the tangent of which is the 
ratio of the minor to the major axis of the ellipse. The ellipticity is directly proportional to the 
differential absorption. Thus CD spectra are often reported in terms of ellipticity (Fasman 
1996). 
 Most biological molecules are chiral and therefore give rise to a CD signal. Since the 
CD signal is sensitive to protein conformation, CD is a method for monitoring secondary 
structure. All major protein secondary structure have their characteristic CD spectra. All- 
proteins show a strong double minimum at 222 and 208 nm and a stronger maximum at 191-
193 nm, which are characteristic of a -helix. All ß-proteins usually have a single negative 
and a single positive CD band. They usually show a single minimum between 210-225 nm 
and a stronger positive maximum between 190-200 nm.  
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Mainly aromatic side chains contribute to the protein near-UV CD spectrum. Since 
aromatic residues are planar (and thus non-chiral), they have very small intrinsic ellipticity in 
the near-UV range. However, if aromatic groups are located in an asymmetric environment 
(such as that resulting from tertiary or quaternary packing), they acquire an induced near-UV 
CD signal. Therefore, near-UV CD spectra of proteins can be used to qualitatively 
characterize tertiary and/or quaternary protein structures. Even though the spectral amplitude 
and sign may vary among different proteins, the wavelengths of the bands corresponding to 
various aromatic groups are relatively well-defined. The strongest contribution to near-UV 
CD usually comes from Trp that has a major peak centered near 295 nm, with a shoulder at 
about 285 nm. Tyr gives a weaker signal centered around 285 nm. Phe has a complex near -
UV CD that may contain multiple bands in the wavelength range from 250-270 (Strickland 
1974).  
 The CD technique is nondestructive to biological samples, requires only a small 
amount of sample, and can be applied to molecules in solution. The limit is that it can only 
give information on secondary structure content, not on detailed molecular structure.    
 
3.20.1. CD experiments 
 CD data were recorded using an upgraded AVIV 62-DS spectropolarimeter equipped 
with a Peltier temperature control. Far-UV CD data (185-250 nm) were collected with 
enzyme solutions (~0.1 mg/ml) in 20 mM PBS, placed in 2 mm cells. Near-UV CD data 
(250-320nm) were measured with similar solutions at 3.2 - 3.5 mg/ml protein placed in 5 mm 
cells. The spectra were recorded with a bandwidth of 1 nm, a step size of 1 nm, and an 
accumulation time per data point of 15 s over two or three scans. The melting curves were 
recorded at 222 and 285 nm during sample heating and consecutive cooling from 25 to 80 oC, 
with a 1 oC increment and an accumulation time per data point of 30 s or 300 s, which 
corresponds to the heating and cooling rates of 80 oC /h or 11 oC /h, respectively. In far-UV 
CD, the signal 222(T) at 222 nm (that is proportional to the protein -helical content) was 
used to monitor thermal unfolding of the EcA2 (WT) and mutants protein. In near-UV CD, 
the largest heat-induced changes in EcA2 (WT) and mutants were observed at 270-280 nm; 
the CD signal at 280 nm, 280(T), was used to monitor these changes, which optimized the 
signal-to-noise ratio. The buffer baselines were subtracted from the data that were 
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normalized to the protein concentration and were expressed as molar residue ellipticity, in 
far-UV CD, and as molar ellipticity in near-UV CD. ORIGIN software was used for the data 
analysis and display. All CD experiments were repeated 2-3 times to ensure reproducibility. 
Heat-induced changes in turbidity were monitored by the dynode voltage V(T) that 
was recorded simultaneously with the CD melting data (T),. The dynode voltage, which is 
high voltage applied to the photomultiplier of the UV detector, is proportional to the 
reduction in the light intensity due to the combined effects of light absorption and scattering. 
Although V(T) does not significantly change during thermal unfolding of non-aggregating 
proteins, our studies of EcA2(WT) and mutants revealed that it increases substantially with 
the heat-induced increase in the particle size, reflecting increased light scattering of these 
particles. Therefore, measuring the V(T) function in CD experiments is useful for monitoring 
the heat-induced changes in the size and/or morphology of EcA2(WT) and mutants. The 
resulting light scattering melting curves are correlated with the DSC data recorded in similar 
heating experiments. 
 
3.20.2 Analysis of CD data 
  At 222 nm, the CD spectra of EcA2 were dominated by the contributions from  
-helices. The -helical content of the protein was roughly proportional to the CD signal 
[]222, and were estimated from the measured ellipticity at 222 nm as: 
 
% -helix = (-[222] + 3.000)/ 39.000 
 
The raw data (in mdeg) was converted to mean residue ellipticity [] by the following 
equation: 
[]= *MRW/(10*l*c) 
 
where, 
  
= CD signal in mdeg, MRW = Mean residue weight of the protein, l= Path length 
of the cell in cm, and c = Protein concentration in mg/ml 
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3.21 Differential Scanning Calorimetry  
The heat capacity Cp(T) of protein samples was recorded at concentrations of 0.4-1.2 
mg/mL in 20 mM PB buffer (pH 8.0) using a model MC-2 differential scanning 
microcalorimeter (Microcal, Amherst, MA), which contained matched Tantalum sample and 
reference cells (volume = 1.2343 ml). The calorimeter was interfaced to an IBM PC via a 
DT-2801 A/D conversion board (Analog Devices, Marlboro, MA) which allows automated 
data collection and analysis. Samples were exhaustively dialyzed at 4 oC against the 
appropriate buffer. Prior to introduction into the calorimeter cells, both dialysate and protein 
were thoroughly degassed under vacuum (without stirring for protein-containing samples) at 
room temperature. The reference solution (dialysate), protein sample, and calorimeter cells 
were at room temperature at the time of sample introduction, and subsequently cooled. 
Degassed protein solution and buffer solutions were subjected to a nitrogen pressure of  
20 psi. The Cp(T) data were recorded during heating at a rate of 90 oC/h (1.5 oC/min) from  
10 oC to the maximal temperature of 100 oC, followed by cooling and incubation at 5 oC for 
1-2 hours before the next scan was recorded. Following the buffer baselines subtraction, the 
data were normalized to protein concentration. Analysis and evaluation of data for 
calorimetric enthalpy (H) values from the heat capacity versus temperature curves and van’t 
Hoff enthalpy (HVH) values were performed using the software provided with the MC-2. 
This analysis uses the methodology and theoretical framework described by Freire and 
Biltonen and Rigell, de Saussure, and Freire. The T, for a given transition was taken to be the 
point of maximum excess heat capacity. The H was calculated from the area under each 
calorimetric peak. Numerical integration of peak areas and resolution of overlapping peaks 
were performed using curve-fitting procedures utilizing either linear baselines (Krishnan et 
al., 1978) or sigmoidal (“spline”) baselines (Fukada et al., 1983) when a change in heat 
capacity of the sample accompanied the thermal transitions. The ratio of the calorimetric to 
van’t Hoff enthalpy (H/HVH) was calculated according to the formula (Biltonen et al., 
1978), 
H/ HVH = H2/CP’max4RTm2 
 
where, H is the calorimetric enthalpy, CP’max, is the maximum in the heat capacity function, 
R is the gas constant, and T, is the transition temperature. This ratio is 1 if the transition is 
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from one state to another (two-state type), greater than 1 if more than two states are involved, 
and may be less than 1 in certain cases if the process is irreversible (Biltonen et al., 1978; 
Privalov et al., 1974; Privalov et al., 1986). 
The molecular weight of asnase II used for calculation of molar quantities was MR 
138,000. This value reflects the molecular weight contribution from the 1304 amino acid 
residues. The EcA2 protein unfolding and the irreversible character of the thermal transitions, 
precluded the quantitative thermodynamic analysis of the calorimetric data. All DSC 
experiments were repeated 2-3 times to ensure reproducibility. 
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4. Results 
4.1 Overview 
The construction and characterization of EcA2 mutants is explained in the following 
schematic flow chart (Figure 4.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Schematic flow chart explaining EcA2 expression and purification. 
 
4.2 Selection of residues for site-directed mutagenesis 
In the context of the present study, we were mainly interested in the function of 
residues at the dimer-dimer interface of the EcA2 protein. Residues to be replaced by site-
directed mutagenesis were selected according to their location in the protein, or due to their 
evolutionary conservation (See Introduction, Figure 1.4) within the class II amidohydrolase 
family. The location of these residues at the dimer-dimer interface and their relationship with 
other residue is shown in Figure 1.8 (see Introduction).  
 Mutagenesis 
Mutagenesis - PCR 
Parent DNA 
Transformation in competent E.coli XL1 - Blue 
Preparation of plasmid - DNA 
Transformation in competent E. coli BL21  
• Restriction analysis 
• Sequencing 
Glycerol culture for ansB gene 
containing expression plasmid 
• Preparation of plasmid DNA 
• Restriction analysis 
Enzyme preparation and purification 
Expression 
Osmotic shock 
Ammonium sulphate precipitation (95%) 
Chromatofocusing 
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Following this, site-directed mutagenesis was used as a tool to create many single 
mutants at the dimer-dimer interface namely EcA2(Y176F), EcA2(Y176S), EcA2(D188N), 
and, EcA2(D156N). On the basis of a mutant constructed earlier in our laboratory i.e. 
EcA2(W66Y) (Derst et al., 1994), we created two more double mutants 
EcA2(W66Y/Y176W), and EcA2(W66Y/Y181W) on the dimer-dimer interface.  
 
4.3 Expression and purification of mutant enzymes 
All enzyme species were readily expressed and purified as previously described for 
EcA2(WT) (Harms et al., 1991). The purification procedure involves only two steps. In the 
first one, the protein is precipitated from the crude periplasmic fluid with ammonium 
sulphate (50-90% saturation). In the second step almost homogenous enzyme is obtained by 
chromatofocusing in the pH range 6.2 to 4.5.  
In chromatofocusing, a pH gradient is formed by equilibrating the column with 
starting buffer and eluting with polybuffer of a lower pH. The choice of the pH range 
depends on the isoelectric point of the protein. The wild type enzyme and most of the other 
engineered mutants had comparable isoelectric points between 4.8–5.0. In the double mutant 
EcA2(W66Y/Y181W), the isoelectric point was about 4.4. All samples were first dialysed 
against 25 mM Piperazine/HCl (pH=5.5, starting buffer) and eluted with 1:10 diluted 
polybuffer (pH=4.0). Some of the mutants showed a second small activity peak in addition to 
the main enzyme fraction. These preparations needed re-chromatofocusing to remove the 
contaminating activity from the main protein peak. Gel filtration was carried out only when 
very high quality purification was required. Samples of elution profiles are shown in figure 
4.2, 4.3, and 4.4. The protein concentration of each fraction was determined by UV 
spectroscopy at 280 nm and enzyme activity was assayed with AHA. In addition, the pH 
value of each fraction was determined. Fractions, the protein concentration of which matched 
asparaginase activity were collected and the enzyme precipitated with ammonium sulphate at 
95 % saturation. The resulting preparations were examined by SDS/PAGE and were at least 
95% pure. Yields varied between 5 and 20 mg of purified enzyme per liter of E. coli culture, 
depending on the stability of the respective protein. By gel filtration, on a calibrated 
Superdex 200 column it was ascertained that the mutants had the native tetrameric structure. 
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Figure 4.2 Purification of EcA2(WT) by chromatofocusing. The elution diagram shown was obtained 
as described in section 3.14. Activity towards 1 mM AHA at pH = 7.0 (mU/ml) and protein 
concentration (mg/ml) are plotted versus fraction number. Elution was by a pH gradient from 6.2-4.5. 
Collected fractions: 40-70 
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Figure 4.3 Purification of mutant EcA2(D188N) by chromatofocusing. The elution diagram shown 
was obtained as described in section 3.14. Activity towards 1 mM AHA at pH = 7.0 (mU/ml) and 
protein concentration (mg/ml) are plotted versus fraction number. Elution was by a pH gradient from 
6.2-4.5. Collected fractions: 13-25. 
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Figure 4.4 Purification of mutant EcA2(D156N) by chromatofocusing. The elution diagram shown 
was obtained as described in section 3.14. Activity towards 1 mM AHA at pH = 7.0 (mU/ml) and 
protein concentration (mg/ml) are plotted versus fraction number. Elution was by a pH gradient from 
6.2-4.5. Collected fractions: 20-36. 
 
4.4 Conformation and stability of EcA2 II 
Denaturation studies are quite useful in establishing the stability of a protein and 
some aspects of its structure in the solution (Pace, 1990). Three independent methods were 
used to estimate the effects of the mutations on the stability of EcA2(WT) and its mutant i.e. 
• equilibrium denaturation in Gu.HCl (monitored by the fluorescence  
 of the only tryptophan residue of EcA2, W66) 
• gel filtration to detect changes in tertiary and quatenary structure 
• thermal denaturation (monitored by activity measurement, circular dichroism (CD), 
 differential scanning calorimetry (DSC), and light scattering).  
 The G(H2O) values derived from chemical denaturation experiments are true 
thermodynamic constants, while in thermal denaturation Tm values are purely empirical 
“melting temperatures,” i.e., the temperature where half of the activity was lost under the 
conditions of the experiments. Due to the different probes used, equilibrium denaturation 
only detected gross changes of conformation (W66 is at a distance of 14 Å from the active 
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site aspartate), while the loss of activity upon thermal denaturation may also reflect small 
local changes in the active sites. 
 
4.4.1 Chemical denaturation studies 
The native conformation of protein is mainly stabilized by non-covalent interactions. 
Therefore, extreme pH values, high temperatures, and chemical substances (denaturants) lead 
to the denaturation of the native conformation. In simple cases, denaturation by chemical 
substance is a reversible two-state process.  
 
 
 
Also EcA2 is tetramer, this simple relationship can be applied to some of the 
EcA2(WT) mutants. The conformational stability of EcA2(WT) and its mutants was 
examined as described in the literature (Derst et al., 1994) by denaturation experiment in 
guanidine hydrochloride solutions. It was reported earlier that the emission maximum of 
asparaginase at 327 to 320 nm is contributed in large part by the tryptophan residues that are 
located in a very hydrophobic environment (Shifrin et al., 1971). 
 
EcA2(WT) 
Fluorescence spectra of EcA2(WT) in several different concentrations of Gu.HCl 
were obtained after excitation at 285 nm, with the result shown in figure 4.5 (A). The 
completely dissociated enzyme in 1.5 M Gu.HCl shows the loss of the 319 nm emission 
maximum and its replacement by a peak at 348 nm, which is characteristics of free 
tryptophan in aqueous solutions (Teale et al., 1957). Indeed, the isoemissive point at 362 nm 
suggests that each spectrum is a combination of not more than two contributing components - 
one being the native and the other the dissociated protein.    
Figure 4.5 B shows the plots of the fluorescence intensity (blue), activity (red), far-
UV CD (green), and emission maximum (magenta) as a function of the molar concentration 
of the Gu.HCl.  
 
Folded (N)                               Unfolded (U)
KNU
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Figure 4.5 (A) Fluorescence spectra of EcA2(WT) at different concentrations of Gu.HCl. (B) 
Gu.HCl-induced denaturation curves of EcA2(WT). The appropriate fraction of denatured protein 
(Fapp) was plotted versus denaturant concentration (Gu.HCl). The data was measured at pH 8.0 and  
25 oC. The curves represent fits of the 2-state (CD) or 3-state model to the data (Section 3.17.2). 
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.  
Parameters Fluorescence CD Activity (max) 
∆GH2O (1) 
(kJ/mol) 
 
38 
 
51 46 62.9 
m (1)
 
(kJ/mol/M) -48.7 -49 -72 -86.6 
∆GH2O (2) 
(kJ/mol) 57.6 -- 61 61.9 
m (2)
 
(kJ/mol/M) -52 -- -74 -60.8 
Xn 0 0 0 0 
Xi 0.06 -- 0.26 0.85 
Xu 0.9 1.0 1.0 1.0 
 
 
Table 4.1 Parameters calculated from the denaturation curves shown in Figure 4.5 B for EcA2(WT) 
in Gu.HCl at pH 8.0, 25 °C. 
 
Unfolding of EcA2(WT) monitored by fluorescence and activity revealed that the 
protein is completely unfolded beyond 1.1 M Gu.HCl. The Gu.HCl-induced unfolding 
process probed by the ellipticity changes at 222 nm (a composite CD signal contributed by 
the secondary structural elements and optically active aromatic groups in the protein) and the 
fluorescence emission maximum shows that EcA2(WT) indicates complete unfolding only 
beyond 1.3 M Gu.HCl.  
The emission maximum is the another fluorescence signal used to monitor protein 
unfolding which usually results in a red shift in the emission of its tryptophan residues, and 
this observation can give a qualitative indication of a significant conformational transition. 
The fact is that the state (native or unfolded) with the larger quantum yield dominates the 
emission maximum, so that the emission maximum (or the center of gravity of the emission 
maximum) will be skewed toward the state with larger quantum yield. Here, in case of the 
emission maximum the apparent transition is shifted to higher denaturant concentration 
(apparent mid-point of 1.1 M and much higher values of G(H2O) and m values, as 
compared to that for the fluorescence data), since the native state has a larger quantum yield 
than the denatured state of the protein (Eftink, 1998). The denaturation parameters estimated 
from the data are summarized in table 4.1. 
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Figure 4.6 (A) Fluorescence spectra, and (B) far-UV CD spectra of EcA2(WT) recorded at different 
pH 5.0-8.0 at 25 oC.  
 
The fluorescence and far-UV CD spectra of EcA2(WT) at pH values ranging from 5.0 to 
8.0 were monitored at room temperature to investigate the pH-dependence of stability. It was 
found that both the fluorescence emission and the CD spectra showed little change at pH 5.0 
(Figsure 4.6 A and 4.6 B). These results suggests that EcA2(WT) does not lose its native 
structure within the pH range 5.0-8.0. 
 In order to study the conformation stability of EcA2(WT) under different pH range 
5.0-8.0, we used emission maximum, fluorescence intensity, far-UV CD, and activity as a 
function of the molar concentration of the Gu.HCl (Figure 4.7). There was a slight shift of 
the profiles to lower Gu.HCl concentrations at pH-values below 7. However,  the calculated 
stabilities expressed as  G(H2O) were 46-50 kJ/mol for all pH-values between 5.0 and 8.0. 
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Figure 4.7 Gu.HCl induced unfolding of EcA2(WT) at 25 oC at different pH 5.0-8.0. (A) shift in the 
emission max (B), ratio F (319/348) (C), ellipticity at 222 nm and (D), activity of the Gu.HCl treated 
protein.  
 
As native asparaginase II is tetrameric, the unfolding profiles may show a 
dependency on protein concentration. However, as shown by figure 4.8 and table 4.2, the  
denaturation parameters for 2 protein concentrations were in fact independent of protein 
concentration, at least in the range tested (100 - 1000 µg/ml).  
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1000 
 
44.0 
+/-8.0 
-46.0 
+/-5.0 
100 48.0 
+/-5.0 
-47.0 
+/-5.0 
 
Table 4.2 Result of denaturation curves (Figure 4.8) analysis for EcA2(WT) in Gu.HCl at pH 8.0, 25 
°C. 
 
Sedimentation equilibrium studies with EcA2(WT) 
 
In order to analyze whether one of the transitions observed by spectroscopic 
techniques is accompanied by a dissociation of tetramers or dimers, we used sedimentation 
equilibrium ultracentrifugation in a high-speed air-turbine centrifuge (Airfuge, Beckman; cf. 
Bothwell et al., 1978). The change of EcA2 quaternary structure with Gu.HCl (0 M-1.5 M) 
was monitored by sedimentation equilibrium (Bothwell et al., 1978).  
Figure 4.9 summarizes the apparent molecular mass of EcA2(WT) as a function of 
different Gu.HCl concentrations (shown on a logarithmatic scale). A typical curve of log F 
versus mass is given as inset. At low Gu.HCl ~0.65 M concentrations, the observed masses 
suggest that tetramers (138 kDa) are in equilibrium with dimers (66 kDa). Between 0.7 and 
0.8 M Gu.HCl, the apparent mass decreases to reach a plateau value of ~36 kDa at 
Figure 4.8 EcA2(WT) at different 
protein conc. in Gu.HCl at pH 8.0, 
25 °C. 
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concentrations above 0.9 M Gu.HCl. This indicated that at higher concentration monomers 
are formed.  
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 These ultracentrifugation results of EcA2(WT) confirmed that at Gu.HCl 
concentrations between 0.5 and 0.8 M the apparent molecular mass indeed decreases from 
that of the tetramer to the expected mass for a monomer. 
 
EcA2(Y176F) 
Denaturation of EcA2(Y176F) with Gu.HCl resulted in a simple one-step unfolding 
profile without any detectable intermediate. The fluorescence spectra of EcA2(Y176F) were 
similar to those of wild-type EcA2 (Figure 4.10 A). The native protein exhibited a emission 
maximum around 319 nm, which shifted to 355 nm at denaturant concentrations > 1.2 M as a 
result of denaturation. All methods applied (ellipticity at 222 nm, and the fluorescence 
intensity at 323 nm) gave nearly indistinguishable denaturation profiles, with a half 
denaturation point (D)50% at 1.29 M Gu.HCl (Figure 4.10 B). In comparison with wild type 
enzyme, the mutant EcA2(Y176F) is significantly more stable with a ∆G(H2O) of ~63.7 
kJ/mol. The denaturation parameters are summarized in table 4.3. As with wild-type enzyme, 
experiments at pH 7 and 8 did not show significant difference in any of denaturation profiles 
(Figure 4.11).  
Figure 4.9 The apparent molecular weight 
of the EcA2(WT) in 50 mM Hepes pH 8.0 
determined by high-speed air centrifuge 
equilibrium sedimentation, as a function of 
different Gu.HCl concentration.  
Inset: Calibration curve for ultra-
centrifugation experiments: dependence of 
the logarithm of fractional protein depletion 
(log F) on protein concentration. Molecular 
weight standards used: (1) Carbonic 
anhydrase (29 kDa), (2) Ovaalbumin (45 
kDa), (3) Bovine serum albumin (66 kDa), 
(4) Phosphorylase B (95 kDa) 
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Figure 4.10 (A) Fluorescence spectra of EcA2(Y176F) at different concentrations of Gu.HCl. (B) 
Gu.HCl-induced denaturation curves of EcA2(Y176F). The appropriate fraction of denature protein 
(Fapp) was plotted versus denaturant concentration (Gu.HCl). The data was measured at pH 8.0 and 
25 oC. The curves correspond to two-state of denaturation 
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Parameters Fluorescence CD 
∆GH2O 
(kJ/mol) 
 
63.7 
 
 
36.5 
 m
 
(kJ/mol/M) -56.0 
 
-32.4 
 
 
Table 4.3 Evaluation of denaturation  analysis for EcA2(Y176F) in Gu.HCl at pH 8.0, 25 °C (Figure 
4.10 B). 
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Figure 4.11 Gu.HCl induced unfolding of EcA2(Y176F) at different pH. (A), shift in the emission 
max (B), ratio F (319/348) (C), ellipticity at 222 nm and (D) activity of the Gu.HCl treated protein.  
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EcA2(W66Y) 
The removal of W66, the fluorescent main probe in wild type EcA2, leaves only the 
11 tyrosine residues of the protein as fluorescent entities. The W66Y variant therefore shows 
an emission spectrum with maximum emission occurring at 310 nm instead of 323 nm 
(Figure 4.12 A) due to the accumulated fluorescence of the tyrosine residues. As shown in 
figure 4.12 B fluorescence measurement gave nearly indistinguishable denaturation profiles, 
with a half denaturation point (D) 50% at 0.69 M Gu.HCl. In comparison with the wild type 
enzyme, the mutant EcA2(W66Y) is slightly less stable with a ∆G(H2O), of 37 to 39 kJ/mol 
at pH 8.0 (Figure 4.12 B). The denaturation parameters are summarized in Table 4.5. Similar 
to EcA2(WT), fluorescence emission and ellipticity of mutant EcA2(W66Y) was 
proportional to protein concentration (Figure 4.13).  
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Figure 4.12 (A) Fluorescence spectra of EcA2(W66Y) at different concentrations of Gu.HCl. (B) 
Gu.HCl-induced denaturation curve of EcA2(W66Y). The appropriate fraction of denature protein 
(Fapp) was plotted versus denaturant concentration (Gu.HCl). The data was measured at pH 8.0 and 
25 oC. The curve corresponds to two-state of denaturation.  
 
  
 
Mutant 
GH2O 
kJ/mol 
m 
kJ/mol/M 
EcA2(W66Y) 36.6 
+/-1.9 
-50.87 
+/-2.7 
 
Table 4.4 Result of denaturation curves (Figure 4.12 B) analysis for EcA2(W66Y) in Gu.HCl at pH 
8.0, 25 °C. 
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EcA2(Y176S)  
 
A third and much more complicated type of behavior was exhibited by variants 
EcA2(Y176S) and EcA2(W66Y/Y181W). Here the onset of denaturation was shifted to 
lower denaturant concentrations. Moreover, the denaturation curves were distinctly 
asymmetric, indicating the formation of an intermediate species. Therefore, three or four-
state models with two or three denaturation equilibria (section 3.17.2) were employed in 
these cases, yielding separate values of ∆G(H2O) and m for each of the equilibria. 
The replacement of Y176 by serine in mutant EcA2(Y176S) results in a drastically 
decreased stability of the enzyme and the appearance of at least two intermediates. In 
fluorescence spectra of EcA2(Y176S), the emission maximum slowly increased from  
319 nm in the absence of Gu.HCl to ~ 330 nm between 0 and 0.6 M Gu.HCl and then shifted 
to 355 nm at 0.8 M Gu.HCl and above (Figure 4.14 A). In the denaturation profiles of 
EcA2(Y176S), as the Gu.HCl concentration increases (Figure 4.14 B), the first property to be 
modified is the activity: half of the initial activity is lost at 0.5 M Gu.HCl, and Y176S is 
completely inactivated above 0.7 M Gu.HCl. The changes in fluorescence and CD are 
biphasic: at 0.2–0.8 M Gu.HCl, a first change corresponds to a relative amplitude of 70-75 
%, and a second occurs for the remaining 25-30 %. The denaturation parameters are 
summarized in table 4.5.  
 
Figure 4.13 EcA2(W66Y) at 
different protein conc. in 0.8 M 
Gu.HCl at pH 8.0, 25 °C. 
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Figure 4.14 (A) Fluorescence spectra of EcA2(Y176S) at different concentrations of Gu.HCl. (B) 
Gu.HCl-induced denaturation curves of EcA2(Y176S). The appropriate fraction of denature protein 
(Fapp) was plotted versus denaturant concentration (Gu.HCl). The data was measured at pH 8.0 and 25 
oC. The CD and fluorescence curves are fits of the 3- and 4-state models, respectively. The activity 
vs. Gu.HCl profile was fitted according to the simple 2-state model.  
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Parameters Fluorescence CD Activity 
∆GH2O (1) 
(kJ/mol) 
 
9 
 
 
30 
 
 
13 
 m (1)
 
(kJ/mol/M) -83.6 
nc*) 
 
 
nc*) 
 ∆GH2O (2) 
(kJ/mol) 
 
7 
 
 
9 
 
 
16.5 
 m (2)
 
(kJ/mol/M) -15.6 
 
-15.8 
 
 
-41 
 ∆GH2O (3) 
(kJ/mol) 
 
45 
 
 
49 
 
- 
m (3)
 
(kJ/mol/M) 
 
-43 
 
 
-41.9 
 
- 
Xn 1.4 
 
-7.1 
 
 
0.56 
 
 
Xi1 
 
 
1.7 
 
 
-9.0 
 
0.97 
 
Xi2 
 
0.80 -3.7 - 
 
Xu 
 
0.64  
-2.9 
 
0.010 
 
Table 4.5 Result of denaturation curves (Figure 4.14 B) analysis for EcA2(Y176S) in Gu.HCl at pH 
8.0, 25 °C. *) nc: no meaningful values could be calculated from the data. 
 
Finding nonsuperimposable transition curves for different parameters shows that 
several intermediate protein forms are present at equilibrium depending on the Gu.HCl 
concentration: 
 
 
 The N  I1 step involves little change in activity, fluorescence and CD, the I1  I2   
step is related to the inactivation of protein and involves the most of the change in 
fluorescence as well as in CD, and complete change in fluorescence and CD occurs in the M 
 U step. Fluorescence measures the degree of shielding from solvent of Trp-66 (Brand & 
Witholt, 1967), and CD reflects the content of secondary structure (Adler et al., 1973). The 
influence of Gu.HCl involves three successive steps: first, the protein first loses its activity, 
then it exposes its Trp-66 to solvent, and finally its secondary structure disappears. This data 
N  I1   U
I II III
I2
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suggest that I1 is the dimeric species (active with a native fluorescence), I2 is a folded 
monomer (retaining most of the secondary structure), and U is a largely unfolded monomeric 
state (both its CD and its intrinsic fluorescence indicate that U has retained some residual 
structure). 
In order to clarify the nature of the intermediate a careful analysis of unfolding with 
CD-spectroscopy was performed. In the denaturation experiment using CD and fluorescence 
spectroscopy, a protein concentration of about 1 mg/ml was used at pH 8.0. The 
EcA2(Y176S) showed a typical far-UV CD spectrum observed for proteins with significant 
–helical contents. The CD spectra of the Gu.HCl-treated protein showed a visible difference 
in the respective CD spectra. Because Gu.HCl was interfering with the CD spectra below 200 
nm, only data in the range of 200-250 nm could be collected.  In Figure 4.15 A & B the 
Gu.HCl denaturation curves at pH 8.0 with CD-spectroscopic and fluorimetric detection are 
shown. No significant changes in the CD and fluorescence spectra occurred between 0 and 
0.6 M Gu.HCl. At 0.8-1.0 M Gu.HCl concentrations, both curves clearly represent a 2-3 step 
denaturation, with a prominent folding intermediate.  
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Figure 4.15 (A) Far-UV CD spectra and (B) fluorescence spectra of EcA2(Y176S) at different 
concentrations of Gu.HCl at pH 8.0, 25 °C.  
 
 In order to study the conformation of EcA2(Y176S) at different pH, we used emission 
maximum, fluorescence intensity, far-UV CD, and activity as a function of the molar 
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concentration of the Gu.HCl (Figure 4.16). There was not a significant difference in the 
emission maximum, fluorescence, and CD profiles at both pH tested. However, the 
EcA2(Y176S) was less stable at pH 5.0 and lost its activity already at very low (~0.15 M) 
concentrations of Gu.HCl. 
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Figure 4.16 Gu.HCl-induced unfolding of EcA2(Y176S) at pH 5.0 & 8.0, 25 oC. (A), shift in the 
emission max (B), maximum fluorescence (C), ellipticity at 222 nm and (D), activity of the Gu.HCl 
treated protein.  
 
EcA2(W66Y/Y181W) 
 
In double mutant EcA2(W66Y/Y181W) a new tryptophan residue was placed at the 
dimer/dimer interface. The fluorescence emission spectrum of this variant was  markedly 
different from that of EcA2(WT) (Figure 4.17 A). In the absence of Gu.HCl, maximum 
emission was seen at 347 nm, as compared to 319 nm for wild-type enzyme. Addition of 
Gu.HCl led to decreased quantum yields and, at the same time, blue-shifted the spectrum in a 
concentration-dependent manner. 
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Figure 4.17 (A) Fluorescence spectra of EcA2(W66Y/Y181W) at different concentrations of Gu.HCl. The 
excitation wavelength was 285 nm. (B) Gu.HCl-induced denaturation curves of EcA2(W66Y/Y181W). The 
appropriate fraction of denatured protein (Fapp) was plotted vs. denaturant concentration. The data was 
measured at pH 8.0 and 25 oC. The curves correspond to three and four-state models of denaturation. The dotted 
lines indicate the calculated fractions of the various species (N, I1, I2 and U). 
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Parameters Fluorescence Activity 
∆GH2O (1) 
(kJ/mol) 
 
7.7 
 
 
13 
 m (1)
 
(kJ/mol/M) -29.1 
 
nc*) 
∆GH2O (2) 
(kJ/mol) 
158 
 
 
16.5 
 m (2)
 
(kJ/mol/M) 
-173 
 
-41 
 ∆GH2O (3) 
(kJ/mol) 
 
94 
 
-- 
m (3)
 
(kJ/mol/M) -283 
 
-- 
Xn 0.403 
 
 
0.56 
 Xi1 
 
0.355 
 
0.97 
Xi2 
 
0.252 
 
-- 
Xu 
 
0.227 
 
0.010 
 
Table  4.6 Result of denaturation curves (Figure 4.17 B) analysis for EcA2(W66Y/Y181W) in 
Gu.HCl at pH 8.0, 25 °C. *) nc: no meaningful values could be calculated from the data 
 
In the denaturation profiles (Figure 4.17 B), the first property to be modified is the 
activity: half of the initial activity is lost at 0.25 M Gu.HCl, and EcA2(W66Y/Y181W) is 
completely inactivated at concentrations above 0.4 M Gu.HCl. The changes in fluorescence 
were biphasic: at 0.1–0.3 M Gu.HCl, a first change corresponds to a relative amplitude of 50-
55 %, and a second occurs for the remaining 45-50 %. The denaturation parameters are 
summarized in table 4.6. Thus, similar to EcA2(Y176S), double mutant 
EcA2(W66Y/Y181W) denaturation showed presence of two intermediates with strongly 
reduced stability. 
In order to clarify the nature of the intermediates a detailed analysis of unfolding with 
CD-spectroscopical techniques was performed. In Figure 4.18 A and B, the Gu.HCl 
denaturation curves at pH 8.0 for CD-spectroscopic and fluorimetric detection are shown. 
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Both curves clearly represent a 2- or 3-step denaturation, with a prominent folding 
intermediate at Gu.HCl concentrations of 0.8 – 1.0 M. 
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Figure 4.18 (A) Far-UV CD spectra and (B) fluorescence spectra of EcA2(W66Y/Y181W) at 
different concentration of Gu.HCl at pH 8.0, 25 °C.  
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Figure 4.19 Gu.HCl-induced unfolding of EcA2(W66Y/Y181W) at different pH 5.0 and 8.0. (A), 
maximum fluorescence (B), activity of the Gu.HCl treated protein. 
 
In order to study the conformation of EcA2(W66Y/Y181W) as a function of pH, we 
used fluorescence intensity, and activity as a function of the molar concentration of the 
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Gu.HCl (Figure 4.19). EcA2(W66Y/Y181W) was found to be less stable at pH 5.0, where it 
lost its activity at very low concentrations of Gu.HCl (~0.15 M). 
 
EcA2(D188N) 
 
 Variant EcA2(D188N) showed fluorescence spectra similar to those of EcA2(Y176S) 
with a gradual increase of the emission maximum from 319 nm to 350 nm (Figure 4.20 A). 
In the denaturation experiment (Figure 4.20 B), half of the initial activity was lost at 0.6 M 
Gu.HCl, and D188N was completely inactivated above 0.9 M Gu.HCl. The changes in 
fluorescence and emission maximum were biphasic: at 0.3–0.6 M Gu.HCl, a first change 
corresponded to a relative amplitude of 50-55 %, and a second occured for the remaining 45-
50 %. The denaturation parameters are summarized in table 4.7.  
Thus, similar to EcA2(Y176S) and EcA2(W66Y/Y181W) denaturation, mutant 
EcA2(D188N) showed the presence of two intermediates with strongly reduced stability. 
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Figure 4.20 (A) Fluorescence spectra of EcA2(D188N) at different concentrations of Gu.HCl. The excitation 
wavelength was 285 nm. (B) Gu.HCl-induced denaturation curves of EcA2(D188N). The appropriate fraction 
of denature protein (Fapp) was plotted versus denaturant concentration (Gu.HCl). The data was measured at pH 
8.0 and 25 oC. The curves correspond to three and four-state of denaturation.  
 
                                                                                                            Chapter 4. Results 
 
 
 71 
Parameters Fluorescence Activity (max) 
∆GH2O (1) 
(kJ/mol) 54.5 
60.2 
 
 
22.4 
 
m (1)
 
(kJ/mol/M) nc
*)
 
 
-63.8 
 
 
-19.0 
 ∆GH2O (2) 
(kJ/mol) 42.3 
 
94.8 
 
50.9 
 
m (2)
 
(kJ/mol/M) 84.7 
 
-77.6 
 
-20.95 
 
∆GH2O (3) 
(kJ/mol)
 
11.9 -- -- 
m (3)
 
(kJ/mol/M) 18.3 -- -- 
Xn 0.69 
 
0.572 
 
320.7 
 
 
Xi1 
 
0.78 0.108 334.9 
 
Xi2 
 
0.71 -- -- 
Xu 
 
0.35 
0.016 
 
344.9 
 
 
 
Table 4.7  Result of denaturation curves (Figure 4.20 B) analysis for EcA2(D188N) in Gu.HCl at pH 
8.0, 25 °C. )*nc: no meaningful values could be calculated from the data 
 
EcA2(D156N) 
Variant EcA2(D156N) showed fluorescence spectra similar to EcA2(Y176S) and 
EcA2(D188N) with a slow increase of the emission maximum from 319 nm to 350 nm 
(Figure 4.21 A). As the Gu.HCl concentration increased (Figure 4.21 B), half of the initial 
activity was lost at 0.45 M Gu.HCl, and D156N was completely inactivated above 0.6 M 
Gu.HCl. The changes in emission maximum and fluorescence were biphasic: at 0.2–0.7 M 
Gu.HCl, a first change corresponded to a relative amplitude of 70-75 %, and a second occurs 
for the remaining 25-30 %. The denaturation parameters are summarized in table 4.8. Again, 
the denaturation profiles of mutant EcA2(D156N) indicated presence of two intermediates 
with strongly reduced stability. 
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Figure 4.21 (A) Fluorescence spectra of EcA2(D156N) at different concentrations of Gu.HCl. The excitation 
wavelength was 285 nm. (B) Gu.HCl-induced denaturation curves of EcA2(D156N). The appropriate fraction 
of denatured protein (Fapp) was plotted versus denaturant concentration (Gu.HCl). The data was measured at pH 
8.0 and 25 oC. The curves correspond to 3 and 4-state of denaturation.  
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Parameters Fluorescence Activity (max) 
∆GH2O (1) 
(kJ/mol) 
 
9.7 
 
 
24.0 
 
 
8.0 
 m (1)
 
(kJ/mol/M) 
 
-17.3 
 
 
-53.5 
 
 
-39.0 
 ∆GH2O (2) 
(kJ/mol) 
 
37.7 
 
-- 
20.4 
 
m (2)
 
(kJ/mol/M) 
 
-19.8 
 
-- 
-41.3 
 
Xn 
 
1.741 
 
 
0.89 
 
 
314.7 
 
Xi 
 
1.062 
 
-- 
 
333.7 
 
Xu 
 
0.821 
 
 
0.016 
 
 
347.7 
 
 
Table 4.8.  Result of denaturation curves (Figure 4.21 B) analysis for EcA2(D156N) in Gu.HCl at pH 
8.0, 25 °C. 
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4.4.2 Gel filtration studies  
 
Changes in oligomerisation state and shape of our EcA2 variants as a function of 
denatuarnt concentration were monitored by size-exclusion chromatography (SEC).  
SEC permits one to evaluate dimensions of protein molecule in different conformers 
(Ackers, 1967, 1970; Davies, 1983; Corbett & Roche, 1984; Uversky, 1993) with high 
accuracy at low concentration (~ 0.01-0.001 mg/ml). It was shown (Corbett & Roche, 1984; 
Uversky et al., 1992, 1993; Uversky, 1993) that a chromatographic FPLC column does not 
shift the equilibrium between the native, molten globule, and unfolded states and therefore 
can be safely applied to study the transitions between these states. 
 Application of size-exclusion chromatography is most promising for studying “all-
or-none” transitions between two states of different compactness, like native-coil (Corbett & 
Roche, 1984; Uversky, 1993) and molten globule-coil (Uversky et al., 1992, 1993) 
transitions. Moreover, SEC in principle provides a possibility to study separately the 
properties of “compact” and “less compact” molecules by collecting a corresponding fraction 
from the column (Uversky et al., 1992, 1993) or by combining SEC with structural methods, 
e.g. with fluorescence. This is a new kind of information since traditional methods (e.g. CD, 
viscosity, etc) provide us with the data averaged over all conformations which exist within 
the transition region. 
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Figure 4.22 Typical standard curve 
for gel filtration  
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 Calculated Molecular weight Elution volume, Ve 
Tetramer 138.4 kDa 12.2 
Dimer 69.2 kDa 13.8 
Monomer 34.6 kDa 15.4 
 
Table : 4.9 Calculated elution volume (Ve) from standard protein (Figure 4.22). 
 Protein samples (1 mg/ml) were incubated for 3 hrs with different concentration of 
Gu.HCl and injected into a Superdex 200 HR 20/30 column connected to a Äkta Explorer 
100 FPLC system, preequilibrated and eluted with different concentration of Gu.HCl in 50 
mM Hepes buffer of pH 8.0 at a flow rate of 0.5 mL/min. Elution was monitored by 
absorbance at 280 nm. The standard molecular mass protein  (1 mg/ml) run in the presence of 
50 mM Hepes pH 8.0 buffer were –amylase (200 kDa), alcohol dehydrogenase (150 kDa), 
BSA(66 kDa) and carbonic anhydrase (29 kDa). The elution volume of tetramer, dimer and 
monomer were calculated (Table 4.10) with standard proteins (Figure 4.22): 
b
V
V
mM
o
e
r +⋅=)log( ,  
where Ve is the elution volume and Vo is the exclusion volume of dextran blue  
(Vo= 8.05 ml). 
 
EcA2(WT) 
The quaternary structure of EcA2(WT) was monitored by gel filtration experiment in 
the presence of increasing amounts of Gu.HCl as described above (Figure 4.23). At 
concentrations between 0 M - 0.8 M Gu.HCl, the protein peak first shifted to higher elution 
volumes, indicating the formation of dimers at 0.6-0.8 M Gu.HCl. At Gu.HCl concentrations 
higher than 0.8 M, the elution volume gradually decreased to values similar to those observed 
in the absence of Gu.HCl. This was accompanied by a distinct broadening of the peak. Peaks 
corresponding to monomers were not observed in any of the experiments. This surprising 
behaviour may be caused by the formation of aggregates of denatured protein (see Discussion).  
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EcA2(W66Y) 
  
 As shown in Figure 4.24, similar results were obtained with variant EcA2(W66Y).  
Again the elution volume first significantly increased and then decreased again at high 
Gu.HCl concentrations without showing any evidence of monomer formation. Aggregation at 
high Gu.HCl concentrations seemed to be even more pronouncing with this mutant. 
 
 
 
Figure 4.23 Gel filtration of 
EcA2(WT) in presence of 
Gu.HCl in 50 mM Hepes (pH 
8.0). Molarity of Gu.HCl is 
indicated on the Figure.  
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EcA2(W66Y/Y181W) 
A completely different behavior was seen with variant EcA2(W66Y/Y181W). At  
0.2-0.4 M Gu.HCl, the elution volume of protein was markedly higher than in the absence of 
denaturant, indicating that the enzyme had dissociated into smaller fragments. From their size 
they might correspond to dimers (peak at Ve = 13.7) and monomers (peak at Ve = 15.8). At 
0.4 M Gu.HCl, all of the protein appeared to be in a monomeric state, while at 0.8 M Gu.HCl 
and above aggregation took place as seen with the other enzyme forms.  
The total area of the peaks was approximately same in all experiments, suggesting 
that no loss of protein occurred during the FPLC runs. The various protein forms were 
analyzed for activity separately. It was found that the first peak eluting by 0.2 M Gu.HCl 
Figure 4.24 Gel filtration of 
EcA2(W66Y) in presence of 
Gu.HCl in 50 mM Hepes (pH 
8.0). Molarity of Gu.HCl is 
indicated on the Figure.  
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(Ve=13.6 ml) was fully active, suggesting that the dimers formed were active. By contrast, 
the putative monomer peak eluted by 0.4 M Gu.HCl was inactive. The peaks appearing at 0.8 
M -1.5 M Gu.HCl did not show any activity as well.  
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Figure 4.25 Gel filtration of 
EcA2(W66Y/Y181W) in the 
presence of Gu.HCl in 50 mM 
Hepes (pH 8.0). Molarity of 
Gu.HCl is indicated on the 
Figure.  
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EcA2(Y176S) 
Variant EcA2(Y176S) showed behavior similar to EcA2(W66Y/Y181W). Again, the 
native protein appeared to dissociate into dimers and monomers at 0.2 M Gu.HCl (Figure 4.26) 
while, a single peak at Ve~12.5 ml was eluted by 1.5 M Gu.HCl. Thus, the gel filtration data 
confirmed the presence of dimers at low Gu.HCl concentrations, which is in agreement with 
the Gu.HCl-denaturation profiles of EcA2(Y176S) (Figure 4.14 B).  
 
10 11 12 13 14 15 16 17 18 19 20
0 MGu.HCl
10 11 12 13 14 15 16 17 18 19 20
0.4 M Gu.HCl
Elution volume, ml
10 11 12 13 14 15 16 17 18 19 20
1.5 M Gu.HCl
 
 
 
 
EcA2(D156N) 
 
As above, this variant dissociated into putative dimers  and monomers at 0.4 M 
Gu.HCl (Figure 4.27). At 0.6 M Gu.HCl concentration, these peaks appeared to merge into a 
third species with an apparent mass between monomer and dimer (Ve ~13.3-14.5 ml), while 
aggregates formed above 0.8 M Gu.HCl. Again, this results agree with the Gu.HCl-
denaturation profiles of EcA2(D156N) (Figure 4.21 B).  
 
 
Figure 4.26 Gel filtration of 
EcA2(Y176S) in presence of 
Gu.HCl in 50 mM Hepes (pH 
8.0). Molarity of Gu.HCl is 
indicated on the Figure.  
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EcA2(D188N) 
 
 The results obtained with EcA2(D188N) are shown in Figure 4.28. With this variant, 
a more complex pattern was observed, indicating that the preparation used was not 
homogeneous or already partially degraded. The peak at about 17.2 ml was present at all 
Gu.HCl concentrations and thus appears to be a due to contaminant. Notwithstanding this 
problem, the general pattern observed with this mutant was rather similar to that seen with 
EcA2(D158N).  
 
Figure 4.27 Gel filtration of 
EcA2(D156N) in presence of 
Gu.HCl in 50 mM Hepes (pH 
8.0). Molarity of Gu.HCl is 
indicated on the Figure. 
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Figure 4.28 Gel filtration of 
EcA2(D188N) in presence of 
Gu.HCl in 50 mM Hepes (pH 
8.0). Molarity of Gu.HCl is 
indicated on the Figure.  
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4.4.3 Thermal denaturation studies 
To understand the effects of temperature and pH on the protein stability, thermal 
denaturation studies were carried out with wild type EcA2 and its mutants. Heating disrupts 
the folded structure of an enzyme because of increased vibrational and rotational motions of 
atoms. Three methods were used to monitor thermal denaturation of the protein, namely 
activity measurements, CD spectroscopy (CD) and differential scanning calorimetry (DSC). 
 
4.4.3.1 Thermal denaturation as monitored by activity  
For thermal denaturation, lower protein concentrations are required than for chemical 
denaturation. Therefore an enzyme concentration of 0.1 mg/ml was used for these 
experiments.  
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In order to follow thermal denaturation by activity measurements, the enzyme was 
first dialyzed against the respective buffer solution and then slowly heated from 25 oC to  
85 oC at a constant rate of 1 oC/min (cf. section 3.17.2). The residual activity of small 
Figure 4.29 Thermal 
denaturation profiles 
of EcA2(WT) & its 
mutants monitored by 
activity. 
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aliquots removed from the sample during heating was immediately measured with 1 mM 
AHA as described in section 3.16.3.  
The resulting profiles for EcA2(WT) and several mutants are compared in figure 
4.30. In each case, the temperature T1/2 at half-denaturation was estimated from the  
inflection point of the profiles. 
 While most variants were inactivated within a narrow temperature range of  about 5 
°C, variant EcA2(Y181W) showed a more complex profile that indicates formation of an 
active intermediate at temperatures between 35 and 40 °C.  Total denaturation took place 
between 45 and 50 °C.  
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Figure  4.30 Thermal renaturation of EcA2(WT) at different protein concentration monitored by 
activity. 
 
 To check whether thermal denaturation was reversible, the experiment was modified 
as follows: EcA2(WT) solutions  with concentrations between 10-1000 µg/ml were incubated 
at 60 oC for 60 min and then  cooled down to 25 oC at a constant rate of 1.2 °C/min. As 
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shown in figure 4.30, the enzyme solution at 100 µg /ml regained up to 90% of its original 
activity, whereas only ~50% recovery was observed at lower and higher protein 
concentrations. Unexpectedly, the most dilute solution (10 µg/ml) was inactivated at the 
lowest rate and did not significantly regain activity after cooling.   
 
4.4.3.2 Thermal denaturation monitored by Circular Dichroism (CD) 
In addition to tryptophan fluorescence, CD spectroscopy was used to evaluate the 
effect of the mutations on the structure and stability of EcA2(WT). Far-UV CD spectroscopy 
is useful to monitor secondary structure, especially -helical structure that comprises a large 
fraction of the EcA2(WT) fold.  
Far-UV CD spectra of predominantly helical proteins have characteristic double 
minima at 208 and 222 nm and a maximum at 193 nm. Near-UV spectroscopy is sensitive to 
the local conformation around aromatic residues. Completely unfolded polypeptides have 
weak near-UV signal, but when the aromatic residues are well packed within a hydrophobic 
core, their CD signal is usually larger than when those same residues are solvent-exposed and 
mobile. Thus, near-UV CD spectroscopy provides a sensitive measure of the tertiary 
structure of proteins and is useful for the qualitative assessment of the packing of the 
aromatic residues. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.31 UV CD spectra of wild-type and mutant proteins. (A) Far-UV CD spectra of EcA2(WT) 
and its mutants. (B) Near-UV CD spectra of EcA2(WT) and its mutants.  
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CD spectroscopy is useful for distinguishing between protein states that are fully 
folded, partially folded or completely unfolded. Completely unfolded proteins lack secondary 
and tertiary structure and thus have little CD signal in the near-UV. The far-UV signal of 
completly unfolded proteins can vary in intensity, but generally has a characteristic “random 
coil” spectrum with a minimum near 203 nm. Molten globule folding intermediates contain 
secondary structure, yet lack a compact well defined hydrophobic core, a characteristic of 
natively folded proteins. As a result, molten globules have a significant far-UV CD signal 
with little near-UV CD signals. Hence, both near- and the far-UV CD spectroscopies are 
necessary to distinguish between an unfolded protein, a molten globule, and a folded protein. 
Figure 4.31 show far-UV and near-UV CD spectra recorded with wild-type and 
mutant EcA2 forms. Figure 4.31 A shows far-UV CD wavelength scans from 190 nm to 250 
nm. The samples contained ~0.1 mg/ml protein in 20 mM PBS, pH 8.0 in 2 mm tightly 
sealed quartz cuvettes. The spectra were recorded at 25 oC, which was the standard 
temperature in our CD experiments. The spectra shows negative peaks at 222 nm and 208 
nm, which are the characteristic for -helices. Based on the CD intensity, the -helical 
content in this protein was estimated to be about 30 % (section 3.20.2). In their native state, 
EcA2(WT) and its mutants have similar amounts of helical structure. 
In addition, near-UV CD spectra were recorded in the range of 250-320 nm. The 
samples contained ~3.4 mg/ml protein in 20 mM PBS, pH 8.0. They were placed in 5 mm 
pathlength quartz cuvettes and the spectra were recorded at 25 oC. The results are shown in 
figure 4.31 B. A well-defined negative trough with a double minimum at 280 nm and 285 nm 
indicates orientational ordering of a significant fraction of the Tyr and Trp groups present in 
wild type EcA2. The spectrum of W66Y had a similar shape, suggesting comparable Trp and 
Tyr packing in wild type and the mutant. In contrast, the near-UV CD spectrum of 
EcA2(W66Y/Y176W) where a new tryptophan residue had been inserted at the dimer-dimer 
interface was significantly different from the others. 
A series of far-UV CD spectra were recorded at several constant temperatures from 
25-73 oC (Figure 4.32). The CD spectral changes upon thermal denaturation of the protein 
reflect the transition from a natively folded to an unfolded state, as indicated by the large 
negative peak at 203 nm observed above 63 °C, which is characteristic of a random coil. As 
already mentioned, the ellipticity minima at 208 and 222 nm in the native spectrum are 
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characteristic of a high degree of -helical secondary structure, and the isochromatic point 
observed near 208.5 nm suggests significant population of only two alternative 
conformations (-helix and random coil). 
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 Another interesting observation was that, at different heating rates, the thermal 
unfolding and refolding curves of wild type protein were significantly different. The 222(T) 
melting curves were recorded during heating and cooling from 25 oC to 85 oC at rates from 
80 oC/h to 11 oC/h (Figure 4.33 A). As the heating rate decreased, the melting curves of 
EcA2(WT) showed a low-temperature shift, with the midpoint Tm of the heat unfolding 
reduced from ~ 67  oC ( = 80 oC/h, red) to ~ 63  oC ( = 11 oC/h, blue). Furthermore, the 
cooling curves (corresponding to refolding of the protein) showed a large scan rate 
dependence and displayed hysteresis at any scan rate explored. This indicates a slow 
irreversible transition with high activation enthalpy and precludes equilibrium 
Figure 4.32  Far-UV CD spectra of 
EcA2(WT) recorded at several 
constant temperatures from 25-73 oC. 
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thermodynamic analysis of this transition. Therefore, the EcA2(WT) unfolding was a non-
equilibrium transition at any scan rate explored.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.33 (A) Thermal unfolding and refolding of EcA2(WT). The thermal transition was 
monitored by CD at 222 nm upon heating and cooling at rate  ~ 11 oC /h (blue) and  ~ 80 oC /h 
(red). Arrows indicate the midpoint Tm of the protein unfolding. (B) First derivative function 
d[222]/dT of the heat unfolding curves. The peak positions shown by arrows indicate the apparent 
melting temperatures Tm. 
 
 
In Figure 4.34, 222(T) melting curves are shown for EcA2(WT) and all mutants 
studied during heating from 25 oC to 85 oC at a rate of 80 oC/h. Most mutants had lower Tm 
values as compared to EcA2(WT). In contrast, the melting curve (Figure 4.34, red curve) of 
EcA2(Y176F) was shifted to higher temperatures (Tm = 71 oC) suggesting higher thermal 
stability of this mutant. Again, hysteresis was observed in the thermal unfolding data of all 
mutants protein, indicating irreversibility of the unfolding transition. 
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Figure 4.35 (inset) shows the far-UV CD wavelength scan of wild type protein at  
25 oC in 20 mM PBS (pH 6.5-8.0) or 20 mM sodium acetate buffer (pH 5.0). The spectra at 
both pH values fully overlapped and showed major negative peaks at 222 nm and 208 nm, 
indicating that the secondary structure of the protein remained invariant in the pH range 
analyzed.  
Nevertheless, the thermal unfolding profiles of EcA2(WT) showed significant 
differences at different pH (Figure 4.35), suggesting reduced protein stability at lower pH. 
Hysteresis was seen at all pH values examined. 
Figure 4.34 Thermal melts of 
EcA2(WT) & its mutants 
monitored by CD at 222 nm.  
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Figure 4.35 Thermal melting curves of EcA2(WT) at different pH monitored by CD at 222 nm.  
Inset: Far-UV CD spectra of EcA2(WT) at different pH.  
 
In addition to measuring CD, the spectropolarimeter was also used to record the 
voltage applied to the dynodes of the UV detector photomultiplier (dynode voltage, V). The 
dynode voltage increases nearly linearly with any reduction in the light intensity at the 
detector which may result from light scattering and/or absorption.  
The melting temperatures indicated by the CD (Figure 4.34) and light scattering 
melting curves of the proteins (Figure 4.36) are similar, indicating that protein unfolding 
leads to aggregation. Thus, the physical origin of the irreversible heat-induced protein 
unfolding appears to be aggregation of the unfolded protein. 
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4.4.3.3 Thermal denaturation monitored by Differential Scanning 
Calorimetry (DSC) 
 The vast majority of stability studies have focused on the thermodynamic 
characterization of small, monomeric globular proteins (Privalov et al., 1979; Murphy et al, 
1992). There are much fewer studies on oligomeric systems because of the high degrees of 
irreversibility in unfolding and the complexity of the overall process (Jaenicke et al., 2000). 
DSC is one of the most powerful methods for the characterization of protein stability (Plum 
et al., 1995). For a thermodynamically reversible transition, the technique provides several 
pieces of information: the melting temperature Tm at which the maximum excess heat 
capacity is observed; the area under the curve, obtained by integration, giving the 
calorimetric enthalpy of denaturation (i.e., transition heat per molecule); the width of the 
Figure 4.36 Thermally induced 
changes in the light scattering of 
EcA2(WT) and its mutants 
monitored by dynode voltage. 
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peak (in °C) at half the maximal excess heat capacity, which is an indication of the co-
operativity of the protein structural change and is related to the vant Hoff’s enthalpy of the 
transition (heat unfolding per cooperative unit); and the change in heat capacity of the protein 
during the heat unfolding transition that is also obtainable from the data. In addition, 
programs are available to analyze the composition of the denaturation curves by 
deconvolution analysis. Since thermal unfolding of EcA2 is thermodynamically irreversible 
due to aggregation, only a limited number of parameters (such as apparent Tm and apparent 
Hcal) can be obtained by DSC. 
 
EcA2(WT)  
Figure 4.37 illustrates typical high-resolution calorimetric data for EcA2(WT) 
solubilized in 20 mM PB (pH 8.0) at different protein concentrations. The Cp(T) data were 
recorded upon heating from 10-80 oC. To facilitate direct comparison of the DSC and CD 
data (inset, Figure 4.37), similar heating rates (80-90 oC/h) were used in both experiments. 
The first DSC scan shows a peak at 66.0 oC, which is close to the apparent Tm = 67 oC 
determined from the CD melting curve, dΘ222(T)/dT. Tm remained invariant with changes in 
the protein concentrations in the range tested, indicating the absence of the effects of protein 
aggregation on the peak position. No transitions were seen upon rescanning of these samples, 
indicating irreversibility of the thermal unfolding. 
Figure 4.38 shows the data fit for the transition in EcA2(WT) over the temperature 
range 10-80 oC based on a 2-state model of denaturation. In figure 4.38 A, the DSC data was 
normalized on the basis of tetrameric structure. HCal/HVH for the transition was nearly 4, 
suggesting that one tetramer comprises about 4 cooperative units, i.e., the cooperative unit 
may be the monomer. Indeed, when the DSC data were normalized to the monomer 
concentration (Figure 4.38 B), the ratio Hcal/HVH was close to unity, confirming that the 
cooperatively unfolding unit in this transition is a monomer. Thus, it appears that the 
monomers in tetrameric EcA2(WT) unfold nearly independently of each other. 
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Figure: 4.37 Thermal denaturation of EcA2(WT) monitored by DSC at different protein 
concentrations at pH 8.0.  
Inset:  Melting of the -helical structure of EcA2(WT) measured by the intensity of the 222-nm 
CD band. 
 
 
 
 
 
 
 
 
 
 
Figure: 4.38 Result of fitting the Cp(T) data (red) by a single Gaussian function using a 2-state 
model; (A) data were normalized on tetramer concentration (B) data were normalized on monomer 
concentration. 
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Figure: 4.39 Thermal denaturation of EcA2(WT) monitored by DSC at different pH.  
 
The thermal stability of EcA2(WT) in the pH range 5.0-8.0 was monitored by DSC 
(Figure 4.39). Similar to the irreversible unfolding observed in our CD and light scattering 
experiments, the thermal unfolding monitored by DSC was irreversible at all pH’s examined, 
as indicated by the absence of the transition from consecutive DSC scans recorded from the 
same sample. In the pH range 5.0-8.0, Tm increased with increasing pH, from 58.0 oC at pH 
5.0 to 67.0oC at pH 8.0.  The highest Hcal values (240 kcal/mol) were observed at pH 8.0, 
which decreased to 197 kcal/mol at pH 5.0. This suggests that the increase in protein stability 
upon increase in pH from 5 to 8 is mainly enthalpy driven. The irreversible nature of the 
thermal transitions prevented further analysis of the data, such as direct determination of the 
heat capacity increment ∆Cp associated with the transition. 
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Figure 4.40 shows that the enthalpies and Tm of EcA2(WT) obtained by DSC & CD 
are linear functions of pH. All thermodynamic parameter determined for EcA2(WT) are 
summarized in table 4.10 at different pH.  
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Figure 4.41 illustrates that the calorimetric enthalpy (per monomer) associated with 
the thermal unfolding of EcA2(WT) at different pH was an approximately linear function of 
Tm. This behavior is expected for a two-state transition and has been observed for a variety of 
small globular proteins (Privalov, 1979). The positive slope of this plot (about 5.3 kcal mol-1 
Figure: 4.40 Enthalpies & 
Tm of EcA2(WT) obtained 
by CD & DSC plotted as a 
function of pH. 
Figure 4.41 Enthalpies of 
EcA2(WT) at different pH 
obtained by DSC plotted against 
the temperature of denaturation. 
The slope of the least-squares 
line indicates the change in heat 
capacity associated with 
denaturation, Cp = 5.3 kcal mol-
1
 K-1 
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K-1 for wild-type protein) represents the difference in the heat capacity at constant pressure 
(Cp) between the folded and the unfolded states of the molecule (heat capacity increment). 
Indeed, by definition ∆Cp=d∆Hcal/dT, which is the slope of the plot ∆Hcal(T). The value of 
Cp is proportional to the magnitude of the hydrophobic interactions in the folded state of a 
protein (the “hydrophobic effect”). The observed value of Cp~5.3 kcal/(mol·K) assessed 
from our measurements at various pH is typical for the unfolding of proteins of this size, 
indicating the consistency of our analysis.  
 
 
pH 
 
Tm (oC) 
determined by CD 
(~80 oC/h) 
Tm (oC) 
determined by DSC 
(~90  oC/h) 
HCal 
(kcal/mol) per monomer 
determined by DSC 
(~80 oC/h) 
5.0 60.0 oC 58.0 oC 197 
6.5 63.0 oC 61.0 oC 222 
8.0 67.0 oC 66.0 oC 240 
 
Table 4.10 Apparent thermodynamic parameters for the thermal denaturation of EcA2(WT) as a 
function of pH. 
 
EcA2(Y176F) 
In the case of variant EcA2(Y176F), a series of DSC experiment similar to those 
described for EcA2(WT) were carried out. The DSC scan shows a peak at 71.0 oC (Figure 
4.42), which is very close to the apparent Tm = 70.7 oC determined from the CD melting 
curve, dΘ222(T)/dT (inset, Figure 4.42). Thus, the DSC peak corresponds to protein unfolding 
transition. Compared to the WT, this mutant shows similar ∆Hcal but significantly higher Tm, 
suggesting increased thermal stability due to the Y176F substitution. 
 Because of the irreversible nature of the transition, (inset, Figure 4.42), no further 
thermodynamic analysis of this transition was carried out. 
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Figure 4.42 Thermal denaturation of EcA2(Y176F) monitored by DSC at different protein 
concentrations at pH 8.0. Inset: Melting of the -helical structure of EcA2(Y176F) measured by the 
intensity of the 222-nm CD band. 
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Figure 4.43 Result of fitting the 
Cp(T) data (red) by a single 
Gaussian function using a 2-state 
model (black); the data were 
normalized to monomer 
concentration. 
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EcA2(W66Y) 
The DSC scan of EcA2(W66Y) mutant shows a peak at 60.2 oC (Figure 4.44), which 
is similar to the apparent Tm = 61.0 oC determined from the CD melting curve, dΘ222(T)/dT 
(inset, Figure 4.44). Therefore, this DSC peak probably reflects protein secondary structural 
unfolding. 
 
EcA2(W66Y/Y176W) 
Double mutant EcA2(W66Y/Y176W) showed a DSC peak centered at 65.0 oC 
(Figure 4.47), which is identical to the apparent Tm = 65.0 oC determined from the CD 
melting curve, dΘ222(T)/dT (inset, Figure 4.46). Thus, this DSC peak corresponds to protein 
secondary structural unfolding. An additional high-temperature peak observed at ~72 oC at a 
relatively high protein concentration of 1.2 mg/ml (Figure 4.46, blue curve), which 
apparently results from aggregation of thermally denatured protein. 
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Figure 4.44 Thermal denaturation of EcA2(W66Y) monitored by DSC at different protein 
concentrations pH 8.0. Inset: Melting of the -helical structure of EcA2(W66Y) measured by the 
intensity of the 222-nm CD band. 
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Figure 4.45 Result of fitting the 
Cp(T) data (red) by a single 
Gaussian function using a 2-state 
model (black); the data were 
normalized to monomer 
concentration. 
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Figure 4.46 Thermal denaturation of EcA2(W66Y/Y176W) monitored by DSC at different protein 
concentrations pH 8.0. Inset: Melting of the -helical structure of EcA2(W66Y/Y176W) measured 
by the intensity of the 222-nm CD band. 
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Figure 4.47 Result of fitting the 
Cp(T) data (red) by a single 
Gaussian function using a 2-state 
model (black); the data were 
normalized to monomer 
concentration. 
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Figure 4.48 Thermal denaturation of EcA2(W66Y/Y181W) monitored by DSC.  
 
EcA2(W66Y/Y181W) 
With double mutant EcA2(W66Y/Y181W) and direct heating from 10 to 80 oC, a 
double peak endotherm was observed (Figure 4.48). The first peak had Tm at 50.4 oC, while 
the second was centered at 55 oC. Similar to other EcA2 proteins, no transitions were seen 
upon sample rescanning, indicating that unfolding was irreversible due to aggregation.  
 
EcA2(Y176S) 
With EcA2(Y176S) at concentrations of 0.15–2.4 mg/ml, the thermal transition 
recorded at a heating rate of 90 oC/h was resolved into three peaks (Figure 4.49). The Tm of 
the 1st peak was ~51 oC, which remained constant over the protein concentrations range 
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tested. The second peak shows variable amplitude and peak temperatures (from 56-52 oC) for 
different protein concentrations. An additional high-temperature peak was observed at the 
highest protein concentration of 1.2 mg/ml (Figure 4.49, blue curve), apparently resulting 
from aggregation of thermally denatured protein. At protein concentrations above 1.2 mg/ml, 
this additional peak broadened and shifted to lower temperatures (Figure 4.49, blue, magenta 
and dark yellow). High-temperature protein aggregation precludes accurate determination of 
Cp in this and other DSC data. 
 
 
Figure 4.49 Thermal denaturation of EcA2(Y176S) monitored by DSC at different protein 
concentrations at  pH 8.0.  All curves are shifted along the Y axis to avoid overlaps. Inset: Melting of 
the -helical structure of EcA2(Y176S) measured by the intensity of the 222-nm CD band. 
 
To monitor the heat-induced changes in particle size, we utilized dynode voltage V(T) 
measurement in the near-UV CD experiment as outlined in Material and Methods (Section 
3.20.1). The heating rate (80 oC/h) used for these CD experiments closely resembles that 
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used in the DSC experiments, thereby facilitating the direct correlation of the Cp(T) and V(T) 
data. The dynode voltage V(T) recorded upon heating at 80 °C/h from 20 to 80 °C remained 
constant up to 52 °C but showed a large increase from 53 to 57 °C followed by a plateau 
(Figure 4.36, yellow). This heat-induced increase in turbidity could not be reversed upon 
cooling, suggesting that it reflects an irreversible increase in the particle size due to protein 
aggregation.  
The irreversible increase in turbidity occured in the same temperature range as the 
second calorimetric transition. Consequently, the second calorimetric transition is 
accompanied by an irreversible aggregation. Thus, the correlation of the DSC and dynode 
data suggests that the first concentration-independent calorimetric peak may involve protein 
unfolding, while the second concentration-dependent peak involves aggregation. However, 
correlation with the far-UV CD melting curve (Tm~57 oC) recorded upon heating of 
EcA2(Y176S) at similar heating rate (inset, Figure 4.49) indicates that the first peak is not 
accompanied by any large cooperative -helical unfolding. We conclude that  
(i)  the first DSC peak, which does not involve substantial secondary structure unfolding 
and thus remains “silent” in far-UV CD, apparently corresponds to the onset of the protein 
unfolding  
(ii) the gradual heat-induced reduction in the protein -helical content observed at high 
temperatures reflects complete unfolding of aggregated protein that is irreversible upon 
cooling.  
 
EcA2(D188N) 
 The thermal transition of variant EcA2(D188N) was resolved into two peaks 
(Figure 4.51). The position of the first peak at Tm ~51.7 oC remained constant over the 
protein concentration range tested. The second peak showed variable amplitude and Tm (from 
56-52 oC) for different protein concentrations, and thus is probably related to aggregation. 
Correlation of these data with the far-UV CD melting curve (Tm~58.5) recorded upon heating 
of EcA2(D188N) (inset, Figure 4.50) shows that the first peak corresponds to the onset of the 
unfolding transition and is not accompanied by any large cooperative -helical unfolding, 
and the second DSC peak corresponds to protein unfolding and aggregation observed by CD 
in the same temperature range. Thus, similar to EcA2(Y176S), EcA2(D188N) appears to be 
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highly prone to aggregation that occurs shortly after the onset of the unfolding transition and 
does not require substantial protein unfolding.  
 
 
Figure: 4.50 Thermal denaturation of EcA2(D188N) monitored by DSC at different protein 
concentrations, pH 8.0. All curves are shifted along the Y axis to avoid overlaps. Inset: Melting of 
the -helical structure of EcA2(D188N) measured by the intensity of the 222-nm CD band.  
 
 
EcA2(D156N) 
 
 Mutant EcA2(D156N) also exhibited two DSC peak (Figure 4.51). The Tm of the 
first one was ~52.4 oC, which remained constant over the whole protein concentration range 
tested. The second peak showed variable amplitude and peak temperatures (from 56-52 oC) 
for different protein concentrations. Correlation of these data with the far-UV CD melting 
curve (Tm~57.7) recorded upon heating of EcA2(D156N) (inset, Figure 4.51) showed that the 
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first peak is not associated with any large cooperative -helical unfolding. Thus, similar to 
EcA2(Y176S) and EcA2(D188N), the first calorimetric peak in EcA2(D156N) appears to 
correspond to the onset of the protein unfolding, and the second DSC peak reflects 
aggregation of the unfolded protein. 
 
Figure 4.51 Thermal denaturation of EcA2(D156N) monitored by DSC at different protein 
concentrations, pH 8.0. All curves are shifted along the Y axis to avoid overlaps.  
Inset: Melting of the -helical structure of EcA2(D156N) measured by the intensity of the 222-
nm CD band. 
 
 Figure 4.52 shows the calorimetric enthalpy (per monomer) of the thermal 
unfolding of EcA2(WT) and selected mutants as a function of the apparent melting 
temperature Tm measured by DSC. This dependence was nearly linear and had a positive 
slope, indicating that the mutation-induced changes in the protein thermal stability (as 
assessed by increase in Tm) had enthalpic origin (as assessed by Hcal). Thus, the mutations 
affect the interatomic interactions in the folded state and hence protein stability. Assuming 
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that the mutations cause minimal effects on the burial of the hydrophobic residues in the 
folded state (and thus on Cp), the slope of the plot Hcal/(Tm) provides an estimate of the 
Cp of EcA2. This estimate, Cp~4.2  kcal/mol K, is in good agreement with the heat 
capacity increment estimated from the pH-dependence of the apparent Tm and Hcal of 
EcA2(WT) (Figure 4.41) confirming the validity of our approach. 
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 The apparent thermodynamic parameters of EcA2(WT) and its mutants monitored 
by activity, CD, and DSC are summarized in table 4.11. 
 
 
 
 
 
 
 
 
 
 
Figure 4.52 Enthalpies of 
EcA2(WT) and its mutant 
obtained by DSC plotted against 
the temperature of denaturation. 
The slope of the least-squares 
line indicates the change in heat 
capacity associated with 
denaturation, Cp = 4.2±2 kcal 
mol-1 K-1.  
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Mutants 
 
Tm (oC) 
determined by 
activity 
(~60 oC/h) 
 
Tm (oC) 
determined by 
CD 
(~80 oC/h) 
Tm (oC) 
determined by 
DSC 
(~90 oC/h) 
HCal 
(kcal/mol) 
per 
monomer 
determined 
by DSC 
(~90 oC/h) 
EcA2(WT) 64.5 oC 67.0 oC 66.0 oC 240 
EcA2(W66Y) -- 61.0 oC 61.0 oC 213 
EcA2(W66Y/ 
Y181W) 39 
oC -- 
1st peak - 50.4 oC), 
2nd peak - Tm is 
conc. dependent 
-- 
EcA2(W66Y/ 
Y176W) -- 65.0 
oC 65.0 oC 219 
EcA2(Y176F) -- 71.0 oC 71.0 oC 254 
EcA2(Y176S) 47 oC 57.0 oC 
1st peak - 51.1 oC, 
2nd peak - Tm is 
conc. dependent 
-- 
EcA2(D188N) 50 oC 58.5 oC 
1st peak  51.7 oC, 
2nd peak - Tm is 
conc. dependent 
-- 
EcA2(D156N) 
-- 
57.7 oC 
1st peak - 52.4 oC, 
2nd peak - Tm is 
conc. dependent 
-- 
 
Table 4.11 Apparent thermodynamic parameters for the thermal denaturation of EcA2(WT) 
& its mutants monitored by activity, CD, and DSC. 
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5. Discussion 
Subunit interactions within proteins are central to enzyme catalysis and enzyme 
regulation. Most enzymes are oligomers and may consist of an equilibrium mixture of 
various molecular forms which is modulated by ligands and other factors. Association-
dissociation processes as well as conformational changes at subunit-subunit interfaces 
constitute most efficient mechanisms for allosteric control. Thus, an  important goal of 
modern enzymology is to understand the role of subunit interactions in more detail in 
oligomeric enzymes (Jaenicke, 1987; Jameson and Seifried, 1999; Jaenicke and Lillie, 2000). 
Today, site-directed mutagenesis has become a standard technique in many laboratories, and 
recent advances in the spectroscopic and thermodynamic methods greatly facilitate the 
analysis of mutant proteins. 
The aim of the present study was to analyze the molecular basis of the interactions 
between the subunits of E. coli asparaginase II (EcA2).  As the clinical use of EcA2 is 
limited by the low stability of the enzyme in the systemic circulation, this matter is not only 
interesting for scientific reasons but also a  better understanding of the subunit interactions in 
EcA2 might provide a basis for the construction  of enzyme variants with increased stability 
and thus a extended lifetime in the patient's bloodstream.  
 
5.1 Experimental approach 
In the first part of this work, we collected data on the stability of wild type EcA2 
using both chemical and thermal denaturation methods. In addition to fluorescence emission 
intensity (the only indicator of conformation used in previous experiments), we also 
employed enzyme activity, fluorescence emission spectra, circular dichroism (CD) and 
differential scanning calorimetry (DSC) as conformational probes. In addition, we examined 
the enzyme's quaternary structure at different denaturant concentrations using size exclusion 
chromatography (SEC).  
We then analyzed the stability of number of mutants with amino acid replacements at 
the dimer-dimer interface. Here, we concentrated on residues at the A/D (or B/C) interface, 
since some information on the role of residues at the A/B interface was already available (see 
Introduction). 
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5.1.1 Spectroscopic properties of EcA2 
EcA2 is readily amenable to spectroscopic studies using tryptophan fluorescence as 
the probe. Wild-type EcA2 contains eleven tyrosines, three histidines, and a single 
tryptophan residue (W66) per monomer. This single tryptophan greatly facilitates the 
interpretation of fluorescence data. Its unusually short wavelength of maximum emission 
(318-320 nm) may be attributed to the low polarity in the environment of this residue  
(Shifrin et al., 1971). Shifrin et al. were the first to describe a red shift of fluorescence 
emission upon urea-induced denaturation of the EcA2 tetramer (Shifrin et al., 1971). In 1974, 
these authors further reported that the refolding of the monomer is complete within seconds, 
whereas the reaggregation of the subunits into the active tetramer is much slower (Shifrin et 
al., 1974). However, in Shifrin's experiments with urea no intermediate states of folding were 
detected except tetramers and monomers. 
Later, equilibrium denaturation experiments with guanidine hydrochloride (Gu.HCl) 
carried out in our laboratory demonstrated that some EcA2 mutants [e.g., EcA2(H87A), 
EcA2(H183L), EcA2(Y181S)] may show complex denaturation profiles that indicate the 
occurrence  of intermediates of dissociation and/or unfolding (Derst et al., 1994). In one 
extreme case, EcA2(D124A), it was established by sedimentation equilibrium 
ultracentrifugation that even in the absence of denaturant a large fraction of this variant 
dissociated into dimers and monomers (Schubert et al., 1996). However, the EcA2 mutants 
used in these early experiments had been constructed to identify catalytically important 
residues and no systematic attempt was made to relate these data to tetramer stabilization 
Tryptophan W66 is located in a microenvironment that responds to changes in the 
active-site region in a very sensitive manner. This fact has not only be utilized to monitor 
denaturation and refolding but also used in a number of other ways, e.g., to study ligand 
binding to EcA2 (Harms et al., 1991), to estimate the pKa of the nearby residue H87 (Wehner 
et al., 1992, Homer et al., 1972), or to follow the movement of a flexible loop that closes the 
active site during catalysis (Aung et al., 2000).  
 
5.1.2 Equilibrium denaturation 
Equilibrium denaturation studies are very useful to explore the structure, stabilization, 
and folding of small, monomeric proteins (Tanford, 1968; Pace, 1986, 1990; Timasheff, 
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1992). The methods for analyzing the energetics of reversible unfolding of proteins by 
thermal or chemical denaturant techniques (Privalov, 1979; Pace, 1986; Privalov & Gill, 
1988) and the conclusions that can be drawn from thorough analysis of a few model proteins 
(Pace, 1986, 1990; Pace et al., 1990) have been reviewed.  
The range of stabilities calculated for monomers is between 6 and 14 kcal/mol (25 -70 
kJ/mol) and represents the small difference between multiple non-covalent interactions 
favoring the folded protein structure and unfavorable entropic terms. Such studies have been 
particularly useful for analysis of packing forces in protein interiors (Alber & Matthews, 
1987; Matsumura et al., 1988), the testing of the globular folding of mutant proteins (Fersht 
et al., 1992), and the functional interaction of residues (Carter et al., 1984). However, 
application of similar techniques to oligomeric proteins has, until recently, been less 
common, despite the potential for providing additional information on subunit interactions. 
Classically, the kinetics of folding pathways have been used to determine the relationship of 
folding to activity of oligomeric proteins and to obtain information on the folding process 
itself (Jaenicke, 1987; Garel, 1992; Price, 1992). On the other hand, the inherent 
thermodynamics of conformational stability of these oligomeric proteins can be deduced 
from equilibrium denaturation studies. 
In the present study, we induced denaturation of EcA2 by guanidine hydrochloride 
(Gu.HCl) and routinely followed the process by measuring the fluorescence of W66. In many 
cases, the effects of the denaturant on secondary structure were also monitored by CD 
spectroscopy.  The denaturation curves for the mutants described here followed a two-state, 
three-state or even four-state mechanism of denaturation. Equilibrium constants KD and the 
corresponding free enthalpies of folding in the absence of denaturant GH2O, were obtained 
by direct fits of appropriate model equations to the denaturation curves. As an additional 
parameter, constant m was derived from the curves which depends on the change in exposure 
to solvent of functional groups when the protein unfolds (Pace, 1986). 
 
5.1.3 Thermal denaturation 
Thermal denaturation is another approach to characterize the stability of a protein. 
The method used here (i.e. monitoring activity while slowly heating enzyme solutions) 
provides results that cannot be directly compared to the results of chemical denaturation, 
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because activity may already be lost due to a local conformational change in the active site 
while the proteins as a whole is still folded. Still, the mid-denaturation temperature Tm (the 
temperature at the inflection point of the activity vs. T profile) is useful to compare the 
stabilities of different enzyme forms.   
By contrast, thermal denaturation monitored by CD can provide useful information on 
the temperature range where gross changes in secondary structure occur. Still more valuable 
are calorimetric techniques  i.e. differential scanning calorimetry (DSC) that - at least in 
favorable cases - provide true thermodynamic parameters related to protein stability.  
 
5.2 Expression and purification of EcA2 mutants 
The mutant used in this work were expressed and purified by a standard protocol 
developed by Harms et al. (1991). The liberation of the periplasmic enzymes by osmotic 
shock is a purification step with a rather selective character. In this way, the periplasmic 
EcA2 is separated from most cellular protein in a very simple manner. Another important 
step is chromatofocusing in the pH range 6 - 4.5, where EcA2 is unusually stable while most 
other enzymes are denatured. The purified EcA2 forms were at least 95 % pure as judged 
from the elution profiles and SDS gels. For mutants with low activity, re-chromatofocusing 
was very important to remove traces of asparaginase activity following the main peak. The 
nature of this additional active species is still not clear. It could be due to small amounts of 
contaminating wild type enzyme or due to traces of asparaginase isozyme I which should be 
present in the BL21Ω host cells. 
 
5.3 Dissociation and unfolding of wild-type EcA2 
5.3.1 Denaturation profiles 
The Gu.HCl-induced unfolding transitions when monitored by activity and 
fluorescence intensity (cf. Figure 4.5) indicate that denaturation of EcA2 (WT) is not a  one-
step process, i.e. the profiles indicate the existence of at least one intermediate form at 
Gu.HCl concentrations between 0.6 and 0.9 M. This putative intermediate is detectable in the 
profiles obtained from fluorescence intensity and activity measurements but not seen in the 
profiles of λmax and CD vs. Gu.HCl concentration indicating that this EcA2 form (or forms)  
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is (are) largely folded and active. This suggests that the intermediates might be "intimate" 
dimers (A/C and B/D, respectively) whereas folded monomers are unlikely to retain activity 
since the active sites are disrupted when monomers form (see below). 
As already mentioned, the shifts of the CD and λmax profiles to higher Gu.HCl 
concentrations (cf. Figure 4.5 B) are expected, since in both spectroscopic techniques the 
native state yields a much higher signal than the denatured one and thus dominates the 
combined signal of both states (Eftink, 1998). When the fraction of denatured state (Fapp) is 
estimated from linear combinations of spectra that represent the fully native and fully 
denatured states, the CD and λmax profiles coincide with those obtained from Fmax and 
activity (not shown). 
 
5.3.2 Sedimentation and gel filtration data 
The results of our sedimentation equilibrium centrifugation experiments (Figure 4.9) 
also suggest that the EcA2 tetramer largely dissociates into smaller fragments before 
unfolding occurs. When considering figure 4.9 it has to be taken into account, however, that 
the method employed is a much simplified form of the sedimentation equilibrium technique 
(see 3.19). The apparent molecular mass calculated from these data, therefore, does not 
necessarily reflect the size distribution of the EcA2 fragments  in an accurate manner.      
At first sight, the results of our gel filtration experiments with wild type EcA2 (Figure 
4.23) seem to be inconsistent with the sedimentation equilibrium centrifugation data.  As 
judged from their elution volumes, the peaks seen at Gu.HCl concentrations of 0.6 M and 0.8 
M seem to be dimers, while no protein was detected at the  position where native monomers 
should have appeared (Ve ≈15.5 ml). The gradual shift of the peaks eluted at 1.0 and 1.2 M 
Gu.HCl to lower elution volume and their considerable broadening is also unexpected and 
needs explanation. 
The observed pattern probably results from two effects. First, it was shown in several 
cases that with increasing denaturant concentrations the volume of denatured proteins also 
considerably increases. This expansion leads to a higher Stokes radius and thus to a lower 
elution volume in gel filtration experiments although the molecular mass of the protein does 
not change (Winzor, 2003). So, for instance, Gualfetti et al. (1999) found that the Stokes 
radius of the monomeric tryptophan synthase α-subunit increased by about 50% between  
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0 M and 8 M urea, leading to a several-fold increase in apparent molecular weight. Similar 
findings were reported by Lee et al. (2003) for the Gu.HCl induced denaturation of δ-
crystallin and by Alcaraz et al. (2004) for rusticyanin and by McDuff et al. (2004) for α-
urease.  
Denaturants like Gu.HCl also can induce protein aggregation. This was for instance 
shown for lactate dehydrogenase from B. megaterium (Kotik et al., 1993) and for other 
proteins as well. The formation of protein aggregates not only leads to an increase of the 
apparent mass but also to a characteristic broadening and tailing of the peaks eluted from gel 
filtration columns (Winzor, 2004).  
Thus, we assume that at intermediate Gu.HCl concentrations wild type EcA2 
dissociates into monomers that appear at unusually low elution volumes due to expansion 
and aggregate when fully denatured at 1 M Gu.HCl and above. Indeed, Kendrick et al. 
(1998) working with interferon-γ showed that Gu.HCl-induced expansion of the protein 
surface was a prerequisite for aggregation.  Our thermal denaturation data confirm that fully 
denatured EcA2 subunits readily aggregate (see below).  
This fact would also explain our finding that the position of the denaturation profiles 
of EcA2 (i.e. the Gu.HCl concentration at half denaturation) ) does not depend on protein 
concentration as would be expected for a simple T  4 M equilibrium (cf. Figure 4.8). It also 
means, however, that the ∆G(H2O) values calculated from the profiles must not be 
considered as true thermodynamic parameters, since the denaturation process is not fully 
reversible. 
 
5.3.3 Thermal denaturation 
Denaturation of wild-type EcA2 was followed by three different methods, i.e. loss of 
activity, CD spectroscopy, and by heat generation measured by DSC. All of these approaches 
yielded comparable values for the temperature of half-denaturation (Tm) between 63 and 67 
°C (Figure 4.29, 4.33, and 4.37, Table 4.11).  This indicates an "all-or-none" behavior, i.e. 
both activity and secondary structure were lost concomitantly in a narrow temperature range 
of about 5 °C. Several observations show that heat denaturation of EcA2(WT) is not an 
equilibrium process: The value of Tm depended on the heating rate, a sharp increase of the 
dynode voltage of the CD spectrometer indicated that a part of the denatured protein 
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immediately aggregated (Figure 4.36) and the melting curves exhibited hysteresis at any of 
the scan rates used.  
Interestingly, a set of CD spectra recorded at constant temperatures around Tm 
exhibited a distinct isochromatic point at about 209 nm (Figure 4.32). This strongly suggests 
that in thermal denaturation only two EcA2 conformations were distinguished by CD 
spectroscopy, the native one with characteristic minima at 222 and 208 nm and a fully 
denatured  species with a minimum at 201 nm. If there were any intermediates during heating 
their secondary structures would not significantly deviate from those of the native or the 
unfolded form.  The single symmetric peak seen in DSC experiments (Figure 4.37) is also 
consistent with  the absence of  significantly populated intermediate states. 
Although the irreversibility of the thermal melting process does not allow a rigorous 
thermodynamic analysis, some interesting semi-quantitative estimates could be obtained. So, 
the cooperative unit of unfolding seems to be the EcA2 monomer. The enthalpy change 
associated with the unfolding of this unit, ∆H, is about 250 kcal/mol (Figure 4.38), and the 
difference of the heat capacities of unfolded and native state (the heat capacity increment 
∆Cp) is about 5 kcal/(mol·K)  as estimated by two different methods (cf. Figs. 4.40 and 4.52). 
 
5.3.4 pH-dependence of EcA2(WT) stability 
Although there is no significant change in the secondary structure distribution of 
wild-type EcA2 between pH 5 and pH 8 (see Figure 4.35) both chemical and thermal 
denaturation data indicate that the overall stability of the enzyme is almost constnt in that 
range with a slight increase of Tm and ∆Hcal with increasing pH (Table 4.10). By contrast, a 
rapid loss in stability sets in below pH 5, possibly brought about by the protonation of 
aspartate and glutamate residues that contribute to the stabilization of the native 
conformation. The DSC data further suggest that the increase in protein stability upon 
increase in pH from 5 to 8 is mainly enthalpy-driven (Figure 4.41). The observed change of 
∆Hcal may reflect deprotonation of residue H183 which has a pKa of about 6.5 and is known 
to affect EcA2 stability (Wehner et al., 1992). 
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5.4 Dissociation and unfolding of EcA2(W66Y) 
 The removal of W66, the main probe for fluorimetric measurement with wild type 
EcA2, leaves only the 11 tyrosine residues as fluorescent entities. As a probe for unfolding 
studies their cumulated fluorescence at 305 nm  (cf. Figure 4.12) is as suitable as that of  
W66.  In Gu.HCl-induced denaturation, EcA2 (W66Y) turned out to be  slightly less stable 
than wild-type enzyme with  a half denaturation point [D]50% at 0.69 M Gu.HCl. at pH 8.0. 
Probably due to the large number of emitting residues which are distributed all over the 
structure, the denaturation profile was strictly symmetrical without any indication of an 
intermediate. 
The behavior of EcA2(W66Y) in analytical gel filtration experiment were similar to 
that of wild-type enzyme (Figure 4.24). The results of thermal denaturation as monitored  by 
CD and DSC yielded a slightly lower Tm of about 61 oC as compared to EcA2 (WT).  
However, the CD spectra of EcA2(W66Y) and EcA2(WT) were indistinguishable (Figure 
4.31) and both the fluorescence emission and the ellipticity of the mutant protein were 
strictly proportional to its concentration in the range between 50 µg/ml and 1000 µg/ml, 
indicating that EcA2(W66Y) is stable down to low protein concentrations. Taken together, 
these findings suggest that the amino acid replacement W66→Y does not  significantly affect 
the native tetrameric structure of EcA2. This is important as variant EcA2(W66Y) was used 
to construct double mutants in which tryptophan residues were introduced into positions 176 
or 181 to serve as selective spectroscopic probes of dissociation-association phenomena 
affecting dimer-dimer contacts (see below). 
 
5.5 The dimer-dimer interface 
As already discussed in the introduction, EcA2 - although a homotetramer - should  
be regarded as a dimer of equivalent dimers.  "Intimate" pairs are formed by subunits A and 
D or B and C, respectively. In the tetramer, the "intimate" dimers have two  areas of contact 
that mainly involve residues 115-125 and 175-195, respectively. The number of direct 
interactions between the dimers is limited, whereas the subunits forming intimate pairs have 
more extended areas of contact. A comparison of the intimate pair BD and the loose pair AD 
is shown in Figure 5.1. From these relationships one would predict that during thermal or 
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chemical denaturation the EcA2 tetramer should first break up into the dimers AC and BD 
before these fragments dissociate to form monomers. 
 
 
 
 
 
 
 
 
 
 
In the present work, we concentrated on the roles of individual amino acids at the 
dimer-dimer interface that connects A with D (or B with C). Figure 5.2 illustrates important 
interactions at the AD contact site in a highly schematic way. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 Stabilizing amino acid 
residues at the AD interface of 
EcA2(WT) 
  
NX = N-terminal domain of subunit X 
CX = C-terminal domain of subunit X 
 
Figure 5.1 Interface 
regions of „intimate“ 
dimer  (BD) compared 
with those of “loose” 
dimer (AD).   
 
Contact sites are marked 
by black bars. 
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 This interface area shows rotational symmetry and is largely made up by residues 175 
- 195 of each monomer. They form hairpin-shaped loops with partial β-sheet conformation 
that are located on the surface of the larger N-terminal domains (NA and ND, respectively) 
and make contact with each other and with the smaller C-terminal domains of the opposing 
subunits CD or CA. The most conspicuous residues in this part of the protein are neighboring 
pairs of tyrosine residues, each one consisting of Y176 of one subunit and Y181 of the other 
(see also Figure 1.8).  As judged from the crystal structure of the EcA2 tetramer, four 
additional pairs of charged residues appear to form salt bridges between the subunits. In the 
center of the interface area, residue R191 of one subunit is bound to D156 of the opposing 
monomer, while two more pairs made up from R195 and D188, respectively, are found at the 
outer limits of the contact area.  In addition to tyrosines 176 and 181 which were replaced 
with various other amino acids, residues 156 and 188 were exchanged for isosteric but 
uncharged asparagine residues to examine the role of the respective salt bridges in tetramer 
stabilization. 
  
 
 
 
 
 
 
 
 
 
 
Figure 5.3 Solvent accessibility of tyrosine residues calculated from the crystal structure of EcA2 
usinf DSSP.  
 
Another factor with relevance for the interpretation of spectroscopic data is the accessibility 
of fluorophors in native, dissociated, and unfolded states of the protein. We, therefore 
Y176-AY176-D
Y176-BY176-C
Y181-D
Y181-C
Y181A
Y181-B
Y181-A
Y176-A
Y176-C
Y181-C
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calculated the accessibility parameters of tyrosine Y176 and Y181 in the EcA2 tetramer and 
in the “intimate” dimers using DSSP (Kabsch and Sander, 1983).  The results are presented 
in graphical form in Figure 5.3. Residue Y176 has very low accessibility in tetramer to 
become exposed to the solvent upon formation of intimate dimers. The accessibility of Y181 
is low in the tetramer and somewhat higher in the dimer.  
 
5.6 Role of Y176 and Y181 in tetramer stabilization  
 Several EcA2 variants afforded information on the role of Y176. EcA2(Y176S) and  
EcA2(Y176F) were thoroughly characterized in this study, while the properties of double 
mutant EcA2(W66Y/Y176W) have been described  by Wendt (2002). 
 
EcA2 (Y176S) 
 The replacement of Y176 with the much smaller serine resulted in a drastically 
decreased stability of the enzyme with the appearance of at least two intermediates. In 
contrast to the mutants described above, several parameters (activity, fluorescence and 
ellipticity) first increased with Gu.HCl concentrations between 0 and 0.2 M (Figure 4.14). 
Between 0.2 M and 0.6 M Gu.HCl enzymatic activity was lost while the spectroscopic 
parameters fell to 60-80% of their initial values. 1.2 M Gu.HCl was necessary for full 
denaturation.  
 The process taking place at low Gu.HCl concentration could be identified by means 
of analytical gel filtration: At 0.2 M Gu.HCl, only dimers were seen, while dimers and 
monomers were present at 0.4 M Gu.HCl (Figure 4.26). The elution volumes of these peaks 
were close to the expected values since the Gu.HCl concentrations required for dissociation 
were low enough not to cause significant expansion of the dissociated fragments (see above).  
As already mentioned, at 0.2 M Gu.HCl the activity of EcA2(Y176S) was even 
higher than in the absence of denaturant indicating that the dimers formed were fully active 
"intimate" pairs which harbor two almost intact catalytic centers, while the active sites are 
disrupted in the loose pairs. The CD data are also consistent with dimer formation as no 
detectable loss of secondary structure took place below  0.4 M Gu.HCl (Figure 4.15).  
The thermal melting curves of EcA2(Y176S) were characterized by a broad transition 
region covering more than 15 °C with a Tm of about 57 °C (Figure 4.34). Again, this is 
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consistent with the presence of unfolding intermediates (Figure 4.35). In DSC an complex 
pattern with three peaks was seen (Figure 4.49). The first one at 51 °C was independent of 
protein concentration and thus could be the result of a first-order process (e.g. dissociation of 
the tetramer into dimers or monomers), while the other two peaks were shifted to lower 
temperatures with increasing protein concentration. The assumption that the peak at 51 °C 
reflects dissociation rather than unfolding is also supported by melting experiments 
monitored by CD (Figure 4.49) which  do not indicate significant loss of secondary structure 
below 55 °C.  Taken together, these observations are consistent with the view that 
replacement of Y176 with a much smaller serine strongly impairs the subunit interactions at 
the AD interface leading to a spontaneous dissociation into dimers. 
 
EcA2 (W66Y/Y176W) 
A mutant with a single tyrptophan residues in position 176 - i.e. 
EcA2(W66Y/Y176W) -was constructed and analyzed by Wendt (2002) as an attempt to 
place a fluorescent residue at the dimer-dimer interface as a direct probe of the dissociation 
and association of the "intimate" dimers. This approach (i.e. the introduction of tryptophan 
residues as site-specific spectroscopic probes)  has been successfully applied earlier, e.g., to 
monitor the loop movement in proteins (Atkinson et al., 1988, Aung et al., 2000)) or to 
characterize intermediates in protein folding pathways (Smit et al., 1991).  
  Surprisingly, the fluorescence of W176 in EcA2(W66Y/Y176W) was not detectable 
in the folded protein, whereas spectra recorded at high Gu.HCl concentrations showed peaks  
typical of a tyrptophan residue in an aqueous environment. The absence of  fluorescence in 
the native double mutant is probably due to strong quenching by neighboring residues. 
Especially acidic amino acids and their amides in the immediate vicinity can act as quenchers 
(Chen and Barkley, 1998). In fact, as illustrated by Figure 5.3, in the native state of EcA2 
residue Y176 is surrounded by three such residues, i.e.  D188, N175 and Q190.    
As W176 in EcA2(W66Y/Y176W is spectroscopically "silent", Wendt (2002) used 
the combined tyrosine fluorescence at 305 nm to follow Gu.HCl-induced denaturation  of this 
variant (cf. Figure 4.12). For the main unfolding step he found a  ∆G(H2O) of  56 kJ/mol, 
 i.e. a value slightly higher than that obtained with wild-type EcA2. This suggests that W176 
exerts the same stabilizing effect on the EcA2 tetramer as the native Y176. This notion is 
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fully supported by our DSC experiments which yielded a Tm of  65 °C  for the double mutant 
(Figure 4.46) as compared to 67 °C for wild-type EcA2. An additional high-temperature DSC 
peak at ~72 oC at high protein concentrations probably resulted from aggregation of the 
thermally denatured protein. 
 
EcA2 (Y176F) 
 Variant EcA2 (Y176F) was constructed to examine whether the phenolic hydroxyl 
group of Y176 is important for its stabilizing function. This appeared reasonable as in the 
wild-type tetramer a hydrogen bond connects this hydroxyl group with the backbone 
carbonyl group  of the opposing D188 (see Figure 1.8). Surprisingly, the replacement did not 
impair stability but markedly increased it. The fluorescence spectrum of EcA2(Y176F) and 
its shift during denaturation were very similar to the situation with wild-type enzyme (Figure 
4.10). The Gu.HCl-induced denaturation profiles also resembled those of EcA2(WT) but 
were shifted to higher Gu.HCl concentrations (1.2 M at pH 8.0), and a calculated ∆G(H2O) 
of about 64 kJ/mol was markedly higher as well. In the gel filtration experiment no 
intermediates were observed. The results of thermal denaturation monitored by CD and DSC 
(Figs. 4.34 and 4.42) were in complete agreement with the chemical denaturation data, 
showing a higher Tm  of  71 oC as compared to 65 °C for EcA2(WT). Thus, the hydroxyl 
group of Y176 is not only dispensable for tetramer stabilization, it even impairs the stability 
of the monomers. 
  An explanation for these findings is suggested by a closer look at the environment of 
Y176 in the EcA2 tetramer (Figure 5.4). The aromatic side chain of Y176 (here Y176-D is 
shown in blue) is located in a narrow cleft mainly formed by polar residues belonging to the 
"hairpin" of the opposing A-subunit (Y181-A, D188-A, Q190-A, and R191-A, yellow). The 
adjacent N175-D also contributes to the structure. Of course, exactly the same configuration 
of residues exists around Y176-A on the other side (not shown in Figure 5.4, see Figure 5.2). 
As the side chain of Y176 almost fills the cleft, it helps to lock the "hairpins" in the optimum 
position. Small side chains in position 176 like the hydroxymethyl group of a serine are 
unable to fill the cleft and thus cannot maintain the required local conformation. This 
weakens the subunit interactions at the AD and BC interfaces and promotes dissociation of 
the native tetramer into dimers AC and BD.  
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Our data further show that phenylalanine and tyrptophan  - both aromatic residues of 
comparable size - can replace tyrosine at position 176. Why they also stabilize the EcA2 
monomers against Gu.HCl-induced denaturation is difficult to explain on the basis of the 
available crystal structures. As shown in Figure 5.3, amino acid 176 is largely exposed to the 
solvent in dimers and monomers and thus should not significantly contribute to their stability. 
Probably the tertiary structure of isolated monomers differs from the conformation they adopt 
in the tetramer so that a less polar residues at position 176 can exert more favorable 
stabilizing interactions than a more polar tyrosine.      
        
 
 
 
 
 
 
 
 
 
 
      
Figure 5.4 Environment of residue Y176 at the AD interface (stereo representation) 
 
EcA2 (W66Y/Y181W) 
Residue Y181 is not far from H183 which, in turn,  is located at an interface where 
three subunits meet. As illustrated by Figure 5.3,  Y181 almost touches Y176 on one side, 
whereas its other side is more easily accessible. Previous mutagenesis studies in our 
laboratory have shown that the mutation Y181F did not affect the stability of the enzyme, 
while - analogous to our results with Y176 - smaller and more polar side chains in this 
position labilize the entire structure. With both EcA2(Y181S) and EcA2(Y181C), the onset 
of denaturation was shifted to lower denaturant concentrations and both species exhibited 
complex denaturation curves with at least one intermediate (Derst et al., 1994).  
 
                                                                                                                                         Chapter 5. Discussion 
 
 121
Adopting the same strategy as above, EcA2(W66Y) was used to construct double 
mutant EcA2(W66Y/Y181W) with a site-specific spectroscopic probe at the dimer-dimer 
interface. Again the resulting enzyme exhibited an unusual fluorescence emission spectrum 
with a maximum at 347 nm in the absence of denaturant. Addition of Gu.HCl did not cause a 
significant red shift, indicating that W181 remained in a distinctly polar environment 
irrespective of denaturant concentration applied (Figure 4.17). Fluorescence intensity, on the 
other hand, strongly varied with denaturant concentration, yielding denaturation profiles of 
very good quality. The profiles were complex but revealed at least two intermediates that 
were both stable within a range of 0.2 M Gu.HCl (Figure 4.17B). By gel filtration the  
intermediates were unequivocally identified as active dimers (i1) which prevailed at 0.2 M 
Gu.HCl and folded monomers (i2) at 0.4 M Gu.HCl (Figure 4.25). The fact that activity was 
totally lost during the transition from i1 and i2 (Figure 4.17B) again confirms that the EcA2 
monomers are inactive even in the folded state.  
Thermal denaturation of the mutant yielded a  Tm of ~ 39 oC when monitored by 
activity. DSC, on the other hand, showed two peaks. The first one (at Tm~50.4) is probably 
related with the unfolding of the protein while the second one (at Tm~55.0) is due to the 
aggregation of the heat-denatured protein (Figure 4.48).   
To summarize our data on the role of Y176 and Y181, it now seems established that 
at both positions aromatic residues are required to ensure sufficient stability of the EcA2 
tetramer. The hydroxyl groups of either residue, on the other hand, are not essential. If the 
inter-subunit hydrogen bonds suggested by the crystal structure (Figure 1.8) really exist in 
solution, they do not appreciably contribute to the stability of the native enzyme. 
 
5.7 Role of D156 and D188 
EcA2 (D188N) 
As already discussed in the introduction an electrostatic interaction connects 
D188(COO-) with R195(Gua+) at dimer–dimer interface (see also Figure 5.2).  Replacement 
of D188 with an isosteric but uncharged asparagine resulted in destabilization of the 
tetrameric structure of the EcA2. Again, active dimers appeared as intermediates of 
denaturation (Figure 4.28). Similar to EcA2(Y176S) and EcA2(W66Y/Y181W), mutant 
EcA2(D188N) showed the presence of two intermediates with highly reduced stability. In 
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agreement with these data, thermal denaturation monitored by activity yielded a reduced Tm 
of ~ 50 oC. In DSC two endothermic peaks appeared. The first one at  Tm~52 oC is probably 
related to the unfolding of the monomers while the second  (Tm ~56-52 oC) indicates 
aggregation of the heat denatured protein.  In summary, we conclude that the salt bridge 
between D188(COO-)---R195(Gua+) markedly contributes to the tetramer stability. 
 
EcA2 (D156N) 
Another electrostatic interaction at dimer–dimer interface involves D156(COO-) and 
R191(Gua+). The absence of this interaction in variant EcA2(D156N) had effects similar to 
those seen with EcA2(D188N): Chemical denaturation profiles indicated the presence of at 
least two intermediates (Figure 4.21), which were identified as dimers and monomers by 
analytical gel filtration (Figure 4.27). Thermal denaturation of EcA2 (D156N) monitored by 
activity showed a Tm at ~ 52.4 oC. As discussed above, the peaks seen in DSC probably 
reflect the unfolding process (at Tm ~ 51.7 °C) while the concentration-dependent signal at 
Tm~ 56-52 oC is caused by aggregation of the unfolded  enzyme.  
 
5.8 Interactions at dimer-dimer interfaces  
From systematic surveys of subunit-subunit interfaces, some general rules on 
oligomer-stabilizing interactions have emerged Glaser et al. (2001) determined the residue-
residue preferences in intermolecular interactions based on a large database of co-crystallized 
protein-protein interfaces. Their results revealed that the highest residue-residue preferences 
at the interface were for interactions between pairs of large hydrophobic residues, and the 
lowest preferences for interactions between pairs of small residues. Experimental studies by 
Vallone et al. have indicated that there is a correlation between the change in the free energy 
of association of the mutants and the change in buried hydrophobic surface area (Vallone et 
al., 1998). Thus, the hydrophobicity of key residues at the subunit interface is expected to be 
the main driving force for protein-protein interactions.  
 Here, we show that some of the key interactions that stabilize the native EcA2 
tetramer do not follow this rule. Although the interaction between Y181 and Y176 is 
predominantly hydrophobic in character, the cleft in which Y176 is inserted is mainly formed 
by polar side chains (see Figure 5.4). Moreover, as judged from our data the salt bridges 
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between D188 and R192 or D156 and R195, respectively, are at least as important in 
stabilizing EcA2 as the tyrosine-tyrosine interactions. In agreement with other studies, our 
results further demonstrate that point mutations at strategic positions can dramatically 
destabilize (or stabilize) large proteins. So, the removal of a single hydroxyl group per EcA2 
monomer - as in EcA2(Y176F) - increased its stability against Gu.HCl-induced denaturation 
by 20 % and its melting temperature by 6 °C without affecting the catalytical properties of 
the enzyme. Thus it appears that biochemical evolution does not try to create proteins with 
the highest possible stability but prefers proteins that are flexible and just stable enough to 
fulfill their task in a natural environment. On the other hand, there are many applications of 
enzymes in biotechnology where maximum stability and resistance against denaturation are 
desirable. A better understanding of the factors that govern protein stability will help "protein 
engineers" to create enzyme variants with such properties. 
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7. Summary 
 
 L-asparaginases (EC 3.5.1.1) catalyze the hydrolysis of L-asparagine to aspartic acid 
and ammonia. Asparaginases of bacterial origin have been used for over 40 years in the 
treatment of acute lymphatic leukemia (ALL). Asparaginase isoenzyme II from Escherichia 
coli (EcA2) is especially effective in cancer therapy. The enzyme, a homotetramer (138 kDa) 
made up from equivalent dimers, is also an ideal model compound to study folding/unfolding 
and association/dissociation phenomenon of a large oligomeric protein: It is readily amenable 
to site-directed mutagenesis, a single tryptophan residue per subunit simplifies spectroscopic 
analysis of conformational changes, and it spontaneously refolds after chemical denaturation. 
Our aim was to probe the molecular basis of the interactions between the EcA2 dimers by 
mutations, and to construct EcA2 variants with improved stability for possible application in 
leukemia treatment. 
 Using guanidine hydrochloride (Gu.HCl) equilibrium denaturation methods, we 
analyzed unfolding of wild-type EcA2 and a number of variants with amino acid 
replacements in the interior of the subunits or at the interfaces between the so-called intimate 
dimers. Enzymatic activity, fluorescence, and CD spectroscopy were used to monitor 
chemical denaturation by Gu.HCl. For wild-type EcA2 we found a highly cooperative 
transition from the folded to the denatured state. By gel filtration and sedimentation 
equilibrium ultracentrifugation, we showed that unfolding of the wild-type enzyme was 
preceded by dissociation into dimers and monomers. EcA2(WT) showed little change in 
stability between pH 5-8 but a rapid loss in stability below pH 5.  
As compared to wild-type enzyme, variants with amino acid exchanges that weaken 
dimer-dimer interactions exhibited more complex denaturation profiles with one or two 
stable intermediate states. So, for instance, variants EcA2(Y176S) and EcA2(W66Y/Y181W) 
dissociate into fully active dimers at low Gu.HCl concentrations. On the other hand, variant 
EcA2(Y176F) shows higher structural stability and specific activity than the wild-type 
protein.  
Thermal unfolding of EcA2 and its mutants was examined by differential scanning 
calorimetry (DSC) and CD. Correlation of DSC, CD, and light scattering data showed a 
single cooperative heat unfolding transition accompanied by irreversible protein aggregation, 
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which precluded quantitative thermodynamic analysis of the excess heat capacity data. DSC 
data of EcA2 (WT) suggested that the increase in protein stability upon an increase in pH 
from 5-8 is mainly enthalpy-driven. Consistent with the chemical unfolding data, mutant 
EcA2(Y176F) showed higher thermal stability (a higher melting temperature, Tm) than wild 
type enzyme while EcA2(Y176S) and EcA2(W66Y/Y181W) were much more heat-sensitive, 
indicating the preference for large hydrophobic side chains at this site. In addition, two salt 
bridges, D156···R191 and D188 ···R195, markedly contribute to the tetramer stability. 
Our results demonstrate that even small changes at a subunit interface may markedly 
enhance or impair EcA2 stability without compromising its catalytic properties. Engineered 
enzyme variants with enhanced stability, such as EcA2(Y176F), are promising candidates for 
an improved asparaginase therapy of leukemias. 
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7. Zusammenfassung 
 L-Asparaginasen (EC 3.5.1.1) katalysieren die Hydrolyse von L-Asparagin zu 
Asparaginsäure und Ammoniak. Asparaginasen bakteriellen Ursprungs werden seit über 40 
Jahren zur Behandlung der Akuten Lymphatischen Leukämie (ALL) eingesetzt. Das 
Isoenzym II der E. coli-Asparaginase (EcA2) ist dabei besonders wirksam. Die  EcA2 ist ein 
Homotetramer, das aus zwei äquivalenten Dimeren aufgebaut ist. Zur Untersuchung von 
Faltung und Denaturierung bzw. Assoziation und Dissoziation oligomerer Proteine ist sie ein 
ideales Modellsystem: das Enzym kann problemlos durch Mutagenese modifiziert werden, 
ein einziger Tryptophanrest pro Untereinheit vereinfacht den spektroskopischen Nachweis 
von Konformationsänderungen, und das Protein renaturiert nach chemischer Denaturierung 
spontan.  Das Ziel der vorliegenden Arbeit war es, durch systematische Mutagenese die 
molekularen Grundlagen der Wechselwirkungen zwischen den EcA2-Dimeren zu klären und 
stabilere EcA2-Varianten für mögliche Anwendungen in der ALL-Therapie zu konstruieren. 
 Zunächst untersuchten wir durch Gleichgewichtsdenaturierung mit Guanidin-
hydrochlorid (Gu.HCl) als Denaturans die  Entfaltung des Wildtypenzyms und einer Serie 
von EcA2-Varianten mit Aminosäureaustauschen im Inneren der Monomeren und an den 
Kontaktflächen zwischen den so genannten "intimen" Dimeren. Um die Denaturierung zu 
verfolgen wurden Aktivitätsmessungen sowie Fluoreszenz- und CD-Spektroskopie 
eingesetzt. Beim Wildtypenzym zeigte sich einen hoch kooperativer Übergang vom nativen 
in den denaturierten Zustand. Durch Gelfiltration und Gkeichgewichtssedimentation konnten 
wir allerdings zeigen dass der Denaturierung eine Dissoziation in Dimere und/oder 
Monomere vorausgeht. Die thermodynamische Stabilität des nativen Enzyms ist zwischen 
pH 5 und 8 nahezu konstant, während sie unterhalb von pH 5 rasch verloren geht.    
 Im Vergleich zum Wildtyp waren die Denaturierungsprofile von Mutanten mit 
modifizierten Dimer-Dimer-Kontakten deutlich komplexer und deuteten auf das Vorliegen 
von einem oder zwei stabilen Zwischenprodukten hin. So dissoziieren z.B. die Varianten 
EcA2(Y176S) und EcA2(W66Y/Y181W) schon bei sehr niedrigen Gu.HCl-Konzentrationen 
in aktive Dimere. Auf der anderen Seite war die Variante EcA2(Y176F) deutlich stabiler und 
auch aktiver als der Wildtyp. 
 Zur Untersuchung der Temperaturstabilität wurde die thermische Denaturierung der 
EcA2-Varianten durch Differential Scanning-Kalorimetrie (DSC) und CD-Spektroskopie 
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verfolgt. Ergänzt durch Lichtstreuungsexperimente, zeigten diese Daten, dass die native 
EcA2 bei etwa 65 °C in einem einzigen hooch kooperativen Prozess denaturiert um dann 
sofort irreversibel zu aggregieren. Wegen der Irreversibilität des Vorgangs war es nicht 
möglich, aus den Daten exakte thermodynamische Parameter abzuleiten. Diee DSC-
Experimente zeigten weiter, dass die Zunahme der thermischen Stabilität des Wildtypenzyms 
zwischen pH 5 und 8 enthalpische Ursachen hat. In Übereinstimmung mit den Ergebnissen 
der chemischen Denaturierung war auch die thermische Stabilität der Variante EcA2(Y176F) 
im Vergleich zum nativen Enzym deutlich erhöht, während  EcA2(Y176S) und 
EcA2(W66Y/Y181W) sehr viel labiler waren. Dies zeigt, dass für eine optimale 
Stabiliserung des EcA2-Tetrameren unpolare aromatische Reste in den Positionen 176 und 
182 notwendig sind. Wir konnten außerdem zeigen, dass Salzbrücken zwischen den 
Aminosäuren D156 und R191 bzw. zwischen D188 und R195 ebenfalls entscheidend zur 
Stabilität daes nativen EcA2-Tetrameren beitragen.  
 Unsere Ergebnisse belegen, dass schon geringe Veränderungen der Kontakte  
zwischen den Untereinheiten die Stabilität der der EcA2 dramatisch erhöhen oder erniedrigen 
können ohne die katalytische Aktivität des Enzyms zu beeinträchtigen. Gezielt veränderte 
EcA2-Varianten wie z.B. EcA2(Y176F) sind viel versprechende Kandidaten  für eine 
verbesserte Asparaginase-Therapie der ALL. 
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8.   Appendix 
8.1 Abbreviations 
8.1.1 General 
 A  Absorption  
 Å  Ångstrom (10-8 cm) 
Amp   Ampicillin 
ansA  Gene of E. coli Asparaginase I   
ansB  Gene of E. coli Asparaginase Il   
ansB*  Mutated gene of E. coli Asparaginase Il   
APS  Ammonium persulfate 
bp  Base pair 
BSA  Bovine serum albumin 
CD  Circular dichroism 
(k)Da  (Kilo) Dalton 
DMSO  Dimethylsulfoxide 
DNA  Deoxyribonucleic acid 
dNTP  Deoxynucleotide phosphate 
dATP  Deoxyadenosine triphosphate 
dGTP  Deoxyguanosine triphosphate 
dCTP  Deoxycytosine triphosphate 
dTTP  Deoxythymidine triphosphate 
DSC  Differential scanning calorimetry 
DTT  Dithiothreitol 
E. coli   Escherichia coli 
EDTA  Ethylenediaminetetraacetic acid 
  Extinction coefficient 
Gu.HCl Guanidine hydrochloride 
IXXX  Fluorescence intensity at XXX nm 
IP  Isoelectric point 
L-AHA L-aspartic acid -hydroxamate
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LB-Medium Luria-Bertani medium 
λEMM.  Wavelength of emission 
M  Molar 
MES  2-[N-Morpholino]-ethanesulfonic acid 
mg  Miligram 
min  Minute 
MOPS  3-[N-Morpholino]-propane sulphonic acid 
ODXXX  Optical Density at  XXX nm wavelength  
PAGE  Polyacrylamide-Gel electrophoresis 
PCR  Polymerase chain reaction 
rpm  Revolutions per minute 
SDS  Sodium dodecylsulphate 
SDS-PAGE Sodium dodecylsulfate polyacrylamide gel electrophoresis 
TAE  Tris Acetate-EDTA 
TCA  Trichloroacetic acid 
TE  Tris-EDTA buffer 
TEMED N,N,N´,N´-Tetramethyl ethylenediamine 
Tris  Tris-(hydroxymethyl)-aminomethane 
U  Activity unit (mol.min-1) 
UV  Ultra voilet 
v/v  Volume by volume 
w/v   Weight by volume 
WT  Wild type 
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8.1.2 Amino acids 
 
Amino acid 3-Letter-Code 1-Letter-Code 
Alanine Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartic acid Asp D 
Cysteine Cys C 
Glutamine Gln Q 
Glutamic acid Glu E 
Glycine Gly G 
Histidine His H 
Isoleucine Ile I 
Leucine Leu L 
Lysine Lys K 
Methionine Met M 
Phenylalanine Phe F 
Proline Pro P 
Serine Ser S 
Threonine Thr T 
Tryptophane Trp W 
Tyrosine Tyr Y 
Valine Val V 
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